Advanced Search (OLGA)

Gene: ADCY9 (adenylate cyclase 9) Homo sapiens

Analyze

Symbol:

ADCY9

Name:

adenylate cyclase 9

RGD ID:

1312370

HGNC Page

HGNC:240

Description:

Enables adenylate cyclase activity. Involved in adenylate cyclase-activating adrenergic receptor signaling pathway and cAMP biosynthetic process. Located in ciliary basal body; cytosol; and plasma membrane.

Type:

protein-coding

RefSeq Status:

REVIEWED

Previously known as:

AC9; ACIX; adenylate cyclase type 9; adenylate cyclase type IX; adenylyl cyclase 9; ATP pyrophosphate-lyase 9; FLJ12046; type IX ATP pyrophosphate-lyase

RGD Orthologs

Alliance Orthologs

More Info

more info ...

More Info

Species	Gene symbol and name	Data Source	Assertion derived from	less info ...
Orthologs ¹				less info ...
Mus musculus (house mouse):	Adcy9 (adenylate cyclase 9)	HGNC	EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):	Adcy9 (adenylate cyclase 9)	RGD	RGD
Chinchilla lanigera (long-tailed chinchilla):	Adcy9 (adenylate cyclase 9)	NCBI	Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):	ADCY9 (adenylate cyclase 9)	NCBI	Ortholog
Canis lupus familiaris (dog):	ADCY9 (adenylate cyclase 9)	HGNC	EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):	Adcy9 (adenylate cyclase 9)	NCBI	Ortholog
Sus scrofa (pig):	ADCY9 (adenylate cyclase 9)	HGNC	EggNOG, Ensembl, NCBI, OrthoDB, Panther, Treefam
Chlorocebus sabaeus (green monkey):	ADCY9 (adenylate cyclase 9)	NCBI	Ortholog
Heterocephalus glaber (naked mole-rat):	Adcy9 (adenylate cyclase 9)	NCBI	Ortholog
Other homologs ²
Rattus norvegicus (Norway rat):	Vom2r16 (vomeronasal 2 receptor, 16)	HGNC	OMA
Alliance orthologs ³
Rattus norvegicus (Norway rat):	Adcy9 (adenylate cyclase 9)	Alliance	DIOPT (Ensembl Compara\|HGNC\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Mus musculus (house mouse):	Adcy9 (adenylate cyclase 9)	Alliance	DIOPT (Ensembl Compara\|HGNC\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Danio rerio (zebrafish):	adcy9 (adenylate cyclase 9)	Alliance	DIOPT (Ensembl Compara\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid\|ZFIN)
Drosophila melanogaster (fruit fly):	Ac13E	Alliance	DIOPT (Ensembl Compara\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Caenorhabditis elegans (roundworm):	acy-1	Alliance	DIOPT (Ensembl Compara\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):	adcy9	Alliance	DIOPT (Ensembl Compara\|OMA\|OrthoFinder\|PANTHER\|PhylomeDB)
Xenopus laevis (African clawed frog):	adcy9.L	Alliance	DIOPT (Xenbase)
Xenopus laevis (African clawed frog):	adcy9.S	Alliance	DIOPT (Xenbase)

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	16	3,953,387 - 4,116,442 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	16	3,953,387 - 4,116,442 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	16	4,012,654 - 4,166,443 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	16	3,952,653 - 4,106,187 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	16	3,952,653 - 4,106,187	NCBI
Celera	16	4,219,322 - 4,372,878 (-)	NCBI		Celera
Cytogenetic Map	16	p13.3	NCBI
HuRef	16	3,981,028 - 4,147,934 (-)	NCBI		HuRef
CHM1_1	16	4,012,672 - 4,166,128 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	16	3,980,710 - 4,143,751 (-)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Annotation Click to see Annotation Detail View

Disease Annotations Click to see Annotation Detail View

epilepsy (IAGP)

Idiopathic Generalized Epilepsy (IAGP)

Kohlschutter-Tonz syndrome (IAGP)

mood disorder (IAGP)

Neurodevelopmental Disorders (IAGP)

Rubinstein-Taybi syndrome (IAGP)

short-rib thoracic dysplasia 9 with or without polydactyly (IAGP)

Gene-Chemical Interaction Annotations Click to see Annotation Detail View

(+)-schisandrin B (ISO)

(1->4)-beta-D-glucan (ISO)

(S)-amphetamine (ISO)

1,2-dimethylhydrazine (ISO)

17alpha-ethynylestradiol (ISO)

17beta-estradiol (EXP,ISO)

2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO)

2,3,7,8-Tetrachlorodibenzofuran (ISO)

2,4-dinitrotoluene (ISO)

4,4'-sulfonyldiphenol (EXP,ISO)

5-fluorouracil (EXP)

6-propyl-2-thiouracil (ISO)

afimoxifene (EXP)

aflatoxin B1 (EXP)

amitrole (ISO)

antirheumatic drug (EXP)

arsane (EXP)

arsenic atom (EXP)

arsenous acid (EXP)

benzo[a]pyrene (EXP,ISO)

benzo[a]pyrene diol epoxide I (EXP)

bisphenol A (EXP,ISO)

bisphenol F (ISO)

butanal (EXP)

caffeine (EXP)

calcium atom (EXP)

calcium(0) (EXP)

cannabidiol (ISO)

cannabigerol (ISO)

carbamazepine (EXP)

carbon nanotube (ISO)

carnosic acid (ISO)

chlorpyrifos (ISO)

cisplatin (EXP)

clotrimazole (EXP,ISO)

colforsin daropate hydrochloride (ISO)

coumarin (EXP)

Cuprizon (ISO)

curcumin (EXP)

cyclosporin A (EXP)

diarsenic trioxide (EXP)

diazinon (EXP)

dibutyl phthalate (ISO)

diclofenac (EXP,ISO)

dicrotophos (EXP)

dorsomorphin (EXP)

econazole (ISO)

epoxiconazole (ISO)

ethanol (ISO)

fenthion (ISO)

flutamide (ISO)

folic acid (ISO)

formaldehyde (ISO)

FR900359 (EXP)

gentamycin (ISO)

isoprenaline (EXP)

ketamine (ISO)

lead(0) (EXP)

leflunomide (EXP)

methoxychlor (ISO)

miconazole (EXP,ISO)

nitrates (ISO)

Nor-9-carboxy-delta9-THC (EXP)

paracetamol (EXP,ISO)

paraquat (ISO)

perfluorooctane-1-sulfonic acid (ISO)

pirinixic acid (ISO)

propiconazole (ISO)

resveratrol (ISO)

rotenone (ISO)

SB 431542 (EXP)

silicon dioxide (EXP)

sodium arsenite (EXP,ISO)

tacrolimus hydrate (EXP)

tert-butyl hydroperoxide (EXP)

testosterone enanthate (ISO)

tetrachloromethane (ISO)

thioacetamide (ISO)

trichostatin A (EXP)

triclosan (EXP)

trimellitic anhydride (ISO)

triphenyl phosphate (EXP)

triptonide (ISO)

troglitazone (ISO)

valproic acid (EXP,ISO)

vinclozolin (ISO)

Gene Ontology Annotations Click to see Annotation Detail View

Biological Process

adenylate cyclase-activating adrenergic receptor signaling pathway (IMP)

adenylate cyclase-activating G protein-coupled receptor signaling pathway (IBA,IDA,IEA)

cAMP biosynthetic process (IDA,IEA,ISO)

cyclic nucleotide biosynthetic process (IEA)

in utero embryonic development (IEA)

intracellular signal transduction (IEA)

signal transduction (TAS)

Cellular Component

axon (IEA,ISO)

ciliary basal body (IDA)

cilium (IDA)

cytosol (IDA)

dendrite (IEA,ISO)

membrane (IDA,IEA)

plasma membrane (IBA,IDA,IEA,TAS)

Molecular Function

adenylate cyclase activity (IBA,IDA,IEA,TAS)

ATP binding (IEA)

lyase activity (IEA)

metal ion binding (IEA)

nucleotide binding (IEA)

phosphorus-oxygen lyase activity (IEA)

protein binding (IPI)

Molecular Pathway Annotations Click to see Annotation Detail View

bile acid transport pathway (IEA)

dilated cardiomyopathy pathway (IEA)

endothelin signaling pathway (EXP)

G protein mediated signaling pathway via Galphas family (TAS)

glutamate signaling pathway (IEA)

gonadotropin-releasing hormone signaling pathway (IEA)

protein kinase A (PKA) signaling pathway (TAS)

purine metabolic pathway (IEA)

vasopressin signaling pathway via receptor type 2 (IEA)

Vibrio cholerae infection pathway (IEA)

Phenotype Annotations Click to see Annotation Detail View

Human Phenotype

Generalized-onset seizure (IAGP)

Seizure (IAGP)

References

References - curated

#	Reference Title	Reference Citation
1.	GOAs Human GO annotations	GOA_HUMAN data from the GO Consortium
2.	KEGG Annotation Import Pipeline	Pipeline to import KEGG annotations from KEGG into RGD
3.	PID Annotation Import Pipeline	Pipeline to import Pathway Interaction Database annotations from NCI into RGD
4.	ClinVar Automated Import and Annotation Pipeline	RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
5.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions
6.	Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies.	Sadana R and Dessauer CW, Neurosignals. 2009;17(1):5-22. Epub 2008 Oct 24.
7.	Molecular analysis, mutation screening, and association study of adenylate cyclase type 9 gene (ADCY9) in mood disorders.	Toyota T, etal., Am J Med Genet 2002 Jan 8;114(1):84-92.

Additional References at PubMed

PMID:2165385	PMID:8662814	PMID:8663304	PMID:9417641	PMID:9628581	PMID:9628827	PMID:10089566	PMID:10807185	PMID:10808179	PMID:10987815	PMID:11299302	PMID:11884542
PMID:12082561	PMID:12168954	PMID:12477932	PMID:12503609	PMID:12626323	PMID:12972952	PMID:14702039	PMID:14993377	PMID:14996950	PMID:15879435	PMID:16344560	PMID:17081983
PMID:19156168	PMID:20101707	PMID:20157112	PMID:20175803	PMID:20459687	PMID:20522523	PMID:20935630	PMID:21873635	PMID:22778270	PMID:23563607	PMID:24269684	PMID:24722286
PMID:24861553	PMID:25277244	PMID:25468996	PMID:25583994	PMID:25959651	PMID:26186194	PMID:26638075	PMID:27880917	PMID:28076799	PMID:28514442	PMID:29292367	PMID:29395067
PMID:29507755	PMID:29568061	PMID:30121334	PMID:30639242	PMID:31056421	PMID:31753913	PMID:31871319	PMID:32515353	PMID:32788342	PMID:32877691	PMID:33232543	PMID:33326832
PMID:33416140	PMID:33845483	PMID:33957083	PMID:33961781	PMID:34079125	PMID:34609279	PMID:34672954	PMID:34709727	PMID:35748872	PMID:35844135	PMID:36111722	PMID:36657828
PMID:36976175	PMID:37579959	PMID:37774976	PMID:37931956	PMID:38117590	PMID:38569033	PMID:39231216

Genomics

Comparative Map Data

ADCY9
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	16	3,953,387 - 4,116,442 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	16	3,953,387 - 4,116,442 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	16	4,012,654 - 4,166,443 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	16	3,952,653 - 4,106,187 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	16	3,952,653 - 4,106,187	NCBI
Celera	16	4,219,322 - 4,372,878 (-)	NCBI		Celera
Cytogenetic Map	16	p13.3	NCBI
HuRef	16	3,981,028 - 4,147,934 (-)	NCBI		HuRef
CHM1_1	16	4,012,672 - 4,166,128 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	16	3,980,710 - 4,143,751 (-)	NCBI		T2T-CHM13v2.0

Adcy9
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	16	4,102,750 - 4,255,094 (-)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	16	4,105,393 - 4,238,362 (-)	Ensembl		GRCm39 Ensembl
GRCm38	16	4,284,886 - 4,437,236 (-)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	16	4,287,529 - 4,420,498 (-)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	16	4,287,545 - 4,419,587 (-)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	16	4,202,773 - 4,334,815 (-)	NCBI		MGSCv36	mm8
Celera	16	4,922,515 - 5,047,165 (-)	NCBI		Celera
Cytogenetic Map	16	A1	NCBI
cM Map	16	2.42	NCBI

Adcy9
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	10	11,645,373 - 11,768,462 (+)	NCBI		GRCr8
mRatBN7.2	10	11,138,966 - 11,262,067 (+)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	10	11,139,446 - 11,262,066 (+)	Ensembl		mRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx	10	15,846,829 - 15,969,423 (+)	NCBI	Rnor_SHR	UTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0	10	15,335,642 - 15,458,268 (+)	NCBI	Rnor_SHRSP	UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0	10	11,004,905 - 11,127,632 (+)	NCBI	Rnor_WKY	UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0	10	11,392,698 - 11,515,406 (+)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	10	11,392,625 - 11,512,600 (+)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	10	10,152,945 - 10,164,223 (+)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	10	11,482,858 - 11,521,569 (+)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
RGSC_v3.1	10	11,482,857 - 11,519,755 (+)	NCBI
Celera	10	10,096,039 - 10,218,487 (+)	NCBI		Celera
Cytogenetic Map	10	q12	NCBI

Adcy9
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0 Ensembl	NW_004955442	13,310,289 - 13,434,971 (+)	Ensembl	ChiLan1.0
ChiLan1.0	NW_004955442	13,310,289 - 13,433,816 (+)	NCBI	ChiLan1.0	ChiLan1.0

ADCY9
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	18	4,487,059 - 4,638,305 (-)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	16	8,270,126 - 8,422,945 (-)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	16	2,882,687 - 3,034,275 (-)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	16	4,056,636 - 4,207,864 (-)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	16	4,059,736 - 4,207,430 (-)	Ensembl	panpan1.1		panPan2

ADCY9
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	6	37,213,251 - 37,334,820 (+)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	6	37,213,227 - 37,331,563 (+)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	6	38,541,290 - 38,662,535 (+)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	6	37,425,913 - 37,547,345 (+)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	6	37,425,366 - 37,544,352 (+)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	6	37,211,737 - 37,333,186 (+)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	6	37,104,933 - 37,226,390 (+)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	6	37,506,497 - 37,627,896 (+)	NCBI		UU_Cfam_GSD_1.0

Adcy9
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024409344	106,257,728 - 106,373,188 (-)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936694	336,269 - 452,943 (+)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936694	336,269 - 449,490 (+)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

ADCY9
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	3	38,103,923 - 38,303,538 (+)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	3	38,117,211 - 38,303,600 (+)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	3	39,139,208 - 39,228,426 (+)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

ADCY9
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	5	3,641,359 - 3,796,697 (-)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
ChlSab1.1 Ensembl	5	3,641,349 - 3,796,198 (-)	Ensembl	ChlSab1.1	ChlSab1.1 Ensembl	chlSab2
Vero_WHO_p1.0	NW_023666068	26,918,925 - 27,157,685 (+)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Adcy9
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla_female_1.0 Ensembl	NW_004624824	1,777,141 - 1,939,071 (-)	Ensembl	HetGla_female_1.0	HetGla_female_1.0 Ensembl	hetGla2
HetGla 1.0	NW_004624824	1,777,141 - 1,902,324 (-)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants

Variants in ADCY9
145 total Variants

Clinical Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
NM_001116.3(ADCY9):c.1694-42690C>G	single nucleotide variant	Lung cancer [RCV000099914]	Chr16:4050248 [GRCh38] Chr16:4100249 [GRCh37] Chr16:16p13.3	uncertain significance
GRCh38/hg38 16p13.3(chr16:3710449-4644951)x3	copy number gain	See cases [RCV000050956]	Chr16:3710449..4644951 [GRCh38] Chr16:3760450..4694952 [GRCh37] Chr16:3700451..4634953 [NCBI36] Chr16:16p13.3	uncertain significance
GRCh38/hg38 16p13.3(chr16:2717952-4041020)x3	copy number gain	See cases [RCV000052395]	Chr16:2717952..4041020 [GRCh38] Chr16:2767953..4091021 [GRCh37] Chr16:2707954..4031022 [NCBI36] Chr16:16p13.3	pathogenic
GRCh38/hg38 16p13.3(chr16:3493167-3993345)x3	copy number gain	See cases [RCV000052396]	Chr16:3493167..3993345 [GRCh38] Chr16:3543167..4043346 [GRCh37] Chr16:3483168..3983347 [NCBI36] Chr16:16p13.3	pathogenic
GRCh38/hg38 16p13.3-13.13(chr16:23141-11296695)x3	copy number gain	See cases [RCV000052367]	Chr16:23141..11296695 [GRCh38] Chr16:73141..11390552 [GRCh37] Chr16:13141..11298053 [NCBI36] Chr16:16p13.3-13.13	pathogenic
GRCh38/hg38 16p13.3(chr16:2850734-7110697)x1	copy number loss	See cases [RCV000053270]	Chr16:2850734..7110697 [GRCh38] Chr16:2900735..7160698 [GRCh37] Chr16:2840736..7100699 [NCBI36] Chr16:16p13.3	pathogenic
NM_001116.3(ADCY9):c.3602G>A (p.Gly1201Asp)	single nucleotide variant	Malignant melanoma [RCV000071122]	Chr16:3966235 [GRCh38] Chr16:4016236 [GRCh37] Chr16:3956237 [NCBI36] Chr16:16p13.3	not provided
NM_001116.3(ADCY9):c.3192C>T (p.Ile1064=)	single nucleotide variant	Malignant melanoma [RCV000071123]	Chr16:3966645 [GRCh38] Chr16:4016646 [GRCh37] Chr16:3956647 [NCBI36] Chr16:16p13.3	not provided
NM_001116.3(ADCY9):c.1869C>T (p.Thr623=)	single nucleotide variant	Malignant melanoma [RCV000071124]	Chr16:4007383 [GRCh38] Chr16:4057384 [GRCh37] Chr16:3997385 [NCBI36] Chr16:16p13.3	not provided
NM_001116.3(ADCY9):c.1354C>T (p.Pro452Ser)	single nucleotide variant	Malignant melanoma [RCV000071125]	Chr16:4114089 [GRCh38] Chr16:4164090 [GRCh37] Chr16:4104091 [NCBI36] Chr16:16p13.3	not provided
GRCh38/hg38 16p13.3-13.13(chr16:46766-11525516)x3	copy number gain	See cases [RCV000133780]	Chr16:46766..11525516 [GRCh38] Chr16:96766..11619372 [GRCh37] Chr16:36766..11526873 [NCBI36] Chr16:16p13.3-13.13	pathogenic
GRCh38/hg38 16p13.3(chr16:46766-4247185)x3	copy number gain	See cases [RCV000136687]	Chr16:46766..4247185 [GRCh38] Chr16:96766..4297186 [GRCh37] Chr16:36766..4237187 [NCBI36] Chr16:16p13.3	pathogenic
GRCh38/hg38 16p13.3(chr16:3560564-4266796)x1	copy number loss	See cases [RCV000137944]	Chr16:3560564..4266796 [GRCh38] Chr16:3610565..4316797 [GRCh37] Chr16:3550566..4256798 [NCBI36] Chr16:16p13.3	pathogenic
GRCh38/hg38 16p13.3(chr16:3820522-4668347)x1	copy number loss	See cases [RCV000137768]	Chr16:3820522..4668347 [GRCh38] Chr16:3870523..4718348 [GRCh37] Chr16:3810524..4658349 [NCBI36] Chr16:16p13.3	pathogenic\|likely pathogenic
GRCh38/hg38 16p13.3(chr16:3303551-3965374)x3	copy number gain	See cases [RCV000138346]	Chr16:3303551..3965374 [GRCh38] Chr16:3353551..4015375 [GRCh37] Chr16:3293552..3955376 [NCBI36] Chr16:16p13.3	likely pathogenic
GRCh38/hg38 16p13.3-13.12(chr16:43732-13326806)x3	copy number gain	See cases [RCV000139166]	Chr16:43732..13326806 [GRCh38] Chr16:93732..13420663 [GRCh37] Chr16:33732..13328164 [NCBI36] Chr16:16p13.3-13.12	pathogenic
GRCh38/hg38 16p13.3(chr16:3726702-4644961)x3	copy number gain	See cases [RCV000142504]	Chr16:3726702..4644961 [GRCh38] Chr16:3776703..4694962 [GRCh37] Chr16:3716704..4634963 [NCBI36] Chr16:16p13.3	pathogenic
GRCh38/hg38 16p13.3-13.11(chr16:666662-15743104)x3	copy number gain	See cases [RCV000143710]	Chr16:666662..15743104 [GRCh38] Chr16:716662..15836961 [GRCh37] Chr16:656663..15744462 [NCBI36] Chr16:16p13.3-13.11	pathogenic
GRCh37/hg19 16p13.3-11.2(chr16:102839-28327676)x3	copy number gain	See cases [RCV000203445]	Chr16:102839..28327676 [GRCh37] Chr16:16p13.3-11.2	pathogenic
GRCh37/hg19 16p13.3-11.2(chr16:1279324-31926800)x3	copy number gain	Breast ductal adenocarcinoma [RCV000207053]	Chr16:1279324..31926800 [GRCh37] Chr16:16p13.3-11.2	uncertain significance
GRCh37/hg19 16p13.3-12.3(chr16:1274615-19073133)x3	copy number gain	Breast ductal adenocarcinoma [RCV000207326]	Chr16:1274615..19073133 [GRCh37] Chr16:16p13.3-12.3	uncertain significance
GRCh37/hg19 16p13.3(chr16:3586972-4099566)x3	copy number gain	See cases [RCV000446299]	Chr16:3586972..4099566 [GRCh37] Chr16:16p13.3	pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:69193-90274381)x3	copy number gain	See cases [RCV000446684]	Chr16:69193..90274381 [GRCh37] Chr16:16p13.3-q24.3	pathogenic
GRCh37/hg19 16p13.3-13.2(chr16:78801-9169448)	copy number gain	See cases [RCV000446555]	Chr16:78801..9169448 [GRCh37] Chr16:16p13.3-13.2	pathogenic
GRCh37/hg19 16p13.3(chr16:97133-5122974)x3	copy number gain	See cases [RCV000445663]	Chr16:97133..5122974 [GRCh37] Chr16:16p13.3	pathogenic
GRCh37/hg19 16p13.3(chr16:4010729-4300636)x1	copy number loss	See cases [RCV000510474]	Chr16:4010729..4300636 [GRCh37] Chr16:16p13.3	uncertain significance
maternal UPD(16p)	complex	Hemimegalencephaly [RCV000494707]	Chr16:1280042..33710558 [GRCh37] Chr16:16p13.3-11.2	pathogenic
GRCh37/hg19 16p13.3(chr16:2891391-4440397)x3	copy number gain	See cases [RCV000511502]	Chr16:2891391..4440397 [GRCh37] Chr16:16p13.3	uncertain significance
GRCh37/hg19 16p13.3-12.2(chr16:85880-22442007)x3	copy number gain	See cases [RCV000511360]	Chr16:85880..22442007 [GRCh37] Chr16:16p13.3-12.2	pathogenic
GRCh37/hg19 16p13.3(chr16:3146027-6362229)x1	copy number loss	See cases [RCV000511703]	Chr16:3146027..6362229 [GRCh37] Chr16:16p13.3	pathogenic
GRCh37/hg19 16p13.3-12.3(chr16:85880-19806921)x3	copy number gain	See cases [RCV000512194]	Chr16:85880..19806921 [GRCh37] Chr16:16p13.3-12.3	pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062)	copy number gain	See cases [RCV000511296]	Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3	pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062)x3	copy number gain	See cases [RCV000512138]	Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3	pathogenic
GRCh37/hg19 16p13.3-13.2(chr16:85880-9883129)x3	copy number gain	See cases [RCV000510698]	Chr16:85880..9883129 [GRCh37] Chr16:16p13.3-13.2	pathogenic
GRCh37/hg19 16p13.3(chr16:1505184-4415346)x3	copy number gain	not provided [RCV000683745]	Chr16:1505184..4415346 [GRCh37] Chr16:16p13.3	pathogenic
GRCh37/hg19 16p13.3-13.13(chr16:85880-11209288)x3	copy number gain	not provided [RCV000683743]	Chr16:85880..11209288 [GRCh37] Chr16:16p13.3-13.13	pathogenic
GRCh37/hg19 16p13.3(chr16:2651354-4460114)x3	copy number gain	not provided [RCV000683747]	Chr16:2651354..4460114 [GRCh37] Chr16:16p13.3	pathogenic
NC_000016.9:g.(?_3929813)_(4387545_?)dup	duplication	Rubinstein-Taybi syndrome 1 [RCV000708038]	Chr16:3879812..4337544 [GRCh38] Chr16:3929813..4387545 [GRCh37] Chr16:16p13.3	uncertain significance
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90274695)x3	copy number gain	not provided [RCV000738918]	Chr16:88165..90274695 [GRCh37] Chr16:16p13.3-q24.3	pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:61451-90294632)x3	copy number gain	not provided [RCV000738915]	Chr16:61451..90294632 [GRCh37] Chr16:16p13.3-q24.3	pathogenic
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90163275)x3	copy number gain	not provided [RCV000738917]	Chr16:88165..90163275 [GRCh37] Chr16:16p13.3-q24.3	pathogenic
GRCh37/hg19 16p13.3(chr16:4163754-4166350)x1	copy number loss	not provided [RCV000751546]	Chr16:4163754..4166350 [GRCh37] Chr16:16p13.3	benign
NM_001116.4(ADCY9):c.2964C>A (p.Leu988=)	single nucleotide variant	not provided [RCV000977845]	Chr16:3966873 [GRCh38] Chr16:4016874 [GRCh37] Chr16:16p13.3	likely benign
NM_001116.4(ADCY9):c.2828+4C>G	single nucleotide variant	not provided [RCV000963684]	Chr16:3977478 [GRCh38] Chr16:4027479 [GRCh37] Chr16:16p13.3	likely benign
NM_001116.4(ADCY9):c.1097C>G (p.Pro366Arg)	single nucleotide variant	not specified [RCV004322368]	Chr16:4114346 [GRCh38] Chr16:4164347 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.3483C>T (p.Phe1161=)	single nucleotide variant	not provided [RCV000947672]	Chr16:3966354 [GRCh38] Chr16:4016355 [GRCh37] Chr16:16p13.3	benign
NM_001116.4(ADCY9):c.2775C>T (p.Thr925=)	single nucleotide variant	not provided [RCV000947673]	Chr16:3977535 [GRCh38] Chr16:4027536 [GRCh37] Chr16:16p13.3	benign
NM_001116.4(ADCY9):c.2715C>T (p.Ala905=)	single nucleotide variant	not provided [RCV000881588]	Chr16:3977595 [GRCh38] Chr16:4027596 [GRCh37] Chr16:16p13.3	benign
NM_001116.4(ADCY9):c.813G>A (p.Ser271=)	single nucleotide variant	not provided [RCV000904374]	Chr16:4114630 [GRCh38] Chr16:4164631 [GRCh37] Chr16:16p13.3	benign
NM_001116.4(ADCY9):c.1690A>C (p.Lys564Gln)	single nucleotide variant	not provided [RCV000971153]	Chr16:4113753 [GRCh38] Chr16:4163754 [GRCh37] Chr16:16p13.3	likely benign
NM_001116.4(ADCY9):c.1738C>T (p.Arg580Cys)	single nucleotide variant	not provided [RCV000906335]	Chr16:4007514 [GRCh38] Chr16:4057515 [GRCh37] Chr16:16p13.3	likely benign
NM_001116.4(ADCY9):c.2520-5C>T	single nucleotide variant	not provided [RCV000900155]	Chr16:3979280 [GRCh38] Chr16:4029281 [GRCh37] Chr16:16p13.3	likely benign
GRCh37/hg19 16p13.3(chr16:109978-4316797)	copy number gain	Chromosome 16p13.3 duplication syndrome [RCV000767731]	Chr16:109978..4316797 [GRCh37] Chr16:16p13.3	pathogenic
NC_000016.10:g.(?_3727698)_(4802591_?)del	deletion	Rubinstein-Taybi syndrome [RCV000813975]	Chr16:3727698..4802591 [GRCh38] Chr16:3777699..4852592 [GRCh37] Chr16:16p13.3	pathogenic
NM_001116.4(ADCY9):c.1981A>G (p.Ser661Gly)	single nucleotide variant	not provided [RCV000970887]	Chr16:3993414 [GRCh38] Chr16:4043415 [GRCh37] Chr16:16p13.3	benign
NM_001116.4(ADCY9):c.2700G>A (p.Ser900=)	single nucleotide variant	not provided [RCV000914791]	Chr16:3977610 [GRCh38] Chr16:4027611 [GRCh37] Chr16:16p13.3	likely benign
NM_001116.4(ADCY9):c.3330C>T (p.Ile1110=)	single nucleotide variant	not provided [RCV000967402]	Chr16:3966507 [GRCh38] Chr16:4016508 [GRCh37] Chr16:16p13.3	benign
NM_001116.4(ADCY9):c.3522C>T (p.Ala1174=)	single nucleotide variant	not provided [RCV000927339]	Chr16:3966315 [GRCh38] Chr16:4016316 [GRCh37] Chr16:16p13.3	likely benign
NM_001116.4(ADCY9):c.708C>T (p.Thr236=)	single nucleotide variant	not provided [RCV000897733]	Chr16:4114735 [GRCh38] Chr16:4164736 [GRCh37] Chr16:16p13.3	likely benign
GRCh37/hg19 16p13.3(chr16:3728113-4114276)x3	copy number gain	not provided [RCV000848614]	Chr16:3728113..4114276 [GRCh37] Chr16:16p13.3	pathogenic
NC_000016.10:g.(?_3744874)_(4337544_?)del	deletion	Rubinstein-Taybi syndrome [RCV001031911]	Chr16:3794875..4387545 [GRCh37] Chr16:16p13.3	pathogenic
GRCh37/hg19 16p13.3(chr16:2651354-4614965)x3	copy number gain	not provided [RCV001006745]	Chr16:2651354..4614965 [GRCh37] Chr16:16p13.3	pathogenic
GRCh37/hg19 16p13.3(chr16:3731117-5325699)x3	copy number gain	not provided [RCV000846351]	Chr16:3731117..5325699 [GRCh37] Chr16:16p13.3	pathogenic
NM_001116.4(ADCY9):c.1665C>A (p.Gly555=)	single nucleotide variant	not provided [RCV000917626]	Chr16:4113778 [GRCh38] Chr16:4163779 [GRCh37] Chr16:16p13.3	benign
GRCh37/hg19 16p13.3(chr16:3469027-4328143)x3	copy number gain	not provided [RCV000849459]	Chr16:3469027..4328143 [GRCh37] Chr16:16p13.3	pathogenic
GRCh37/hg19 16p13.3(chr16:4094972-4183909)x1	copy number loss	not provided [RCV001006747]	Chr16:4094972..4183909 [GRCh37] Chr16:16p13.3	likely benign
NM_001116.4(ADCY9):c.688G>A (p.Val230Met)	single nucleotide variant	not specified [RCV004288618]	Chr16:4114755 [GRCh38] Chr16:4164756 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.1900G>A (p.Gly634Arg)	single nucleotide variant	not specified [RCV004288096]	Chr16:3993495 [GRCh38] Chr16:4043496 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.183G>A (p.Gly61=)	single nucleotide variant	not provided [RCV000878981]	Chr16:4115260 [GRCh38] Chr16:4165261 [GRCh37] Chr16:16p13.3	benign
NM_001116.4(ADCY9):c.147C>T (p.Ser49=)	single nucleotide variant	not provided [RCV000917627]	Chr16:4115296 [GRCh38] Chr16:4165297 [GRCh37] Chr16:16p13.3	benign
NM_001116.4(ADCY9):c.489C>T (p.Thr163=)	single nucleotide variant	not provided [RCV000971154]	Chr16:4114954 [GRCh38] Chr16:4164955 [GRCh37] Chr16:16p13.3	benign
NM_001116.4(ADCY9):c.2632C>T (p.Leu878=)	single nucleotide variant	not provided [RCV000906623]	Chr16:3979163 [GRCh38] Chr16:4029164 [GRCh37] Chr16:16p13.3	benign
NM_001116.4(ADCY9):c.2994C>T (p.Arg998=)	single nucleotide variant	not provided [RCV000948971]	Chr16:3966843 [GRCh38] Chr16:4016844 [GRCh37] Chr16:16p13.3	benign\|likely benign
NC_000016.10:g.(?_3727698)_(4802591_?)dup	duplication	Amelocerebrohypohidrotic syndrome [RCV001031942]	Chr16:3777699..4852592 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2519+10G>A	single nucleotide variant	not provided [RCV000890592]	Chr16:3983222 [GRCh38] Chr16:4033223 [GRCh37] Chr16:16p13.3	likely benign
GRCh37/hg19 16p13.3(chr16:4005376-4094972)x1	copy number loss	not provided [RCV001006746]	Chr16:4005376..4094972 [GRCh37] Chr16:16p13.3	uncertain significance
GRCh37/hg19 16p13.3-11.2(chr16:2959279-30190593)x3	copy number gain	See cases [RCV001263169]	Chr16:2959279..30190593 [GRCh37] Chr16:16p13.3-11.2	pathogenic\|likely pathogenic
NM_001116.4(ADCY9):c.3098G>C (p.Arg1033Thr)	single nucleotide variant	Neurodevelopmental disorder [RCV001262985]	Chr16:3966739 [GRCh38] Chr16:4016740 [GRCh37] Chr16:16p13.3	uncertain significance
GRCh37/hg19 16p13.3(chr16:84485-5251013)x3	copy number gain	not provided [RCV001537890]	Chr16:84485..5251013 [GRCh37] Chr16:16p13.3	pathogenic
GRCh37/hg19 16p13.3(chr16:85880-5249457)x3	copy number gain	not provided [RCV001259749]	Chr16:85880..5249457 [GRCh37] Chr16:16p13.3	pathogenic
NC_000016.9:g.(?_3777699)_(4852592_?)dup	duplication	Kohlschutter's syndrome [RCV001305610]	Chr16:3777699..4852592 [GRCh37] Chr16:16p13.3	uncertain significance
NC_000016.9:g.(?_3929813)_(4387545_?)dup	duplication	Rubinstein-Taybi syndrome [RCV001308817]\|Rubinstein-Taybi syndrome due to CREBBP mutations [RCV000708038]	Chr16:3929813..4387545 [GRCh37] Chr16:16p13.3	uncertain significance
NC_000016.10:g.3619617_4448281del	deletion	See cases [RCV003313806]	Chr16:3619617..4448281 [GRCh38] Chr16:16p13.3	pathogenic
NC_000016.9:g.(?_256302)_(5971108_?)dup	duplication	Familial Mediterranean fever [RCV001877532]\|Fanconi anemia [RCV001877533]\|not provided [RCV001877531]	Chr16:256302..5971108 [GRCh37] Chr16:16p13.3	uncertain significance
NC_000016.9:g.(?_256302)_(4852572_?)dup	duplication	Epilepsy [RCV003113403]\|Idiopathic generalized epilepsy [RCV003109446]\|Saldino-Mainzer syndrome [RCV003113404]	Chr16:256302..4852572 [GRCh37] Chr16:16p13.3	uncertain significance
NC_000016.9:g.(?_3293141)_(5971108_?)dup	duplication	Rubinstein-Taybi syndrome [RCV003113465]	Chr16:3293141..5971108 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2905C>T (p.Arg969Cys)	single nucleotide variant	not specified [RCV004301643]	Chr16:3966932 [GRCh38] Chr16:4016933 [GRCh37] Chr16:16p13.3	uncertain significance
GRCh37/hg19 16p13.3(chr16:111043-6627459)x3	copy number gain	See cases [RCV002292215]	Chr16:111043..6627459 [GRCh37] Chr16:16p13.3	pathogenic
GRCh37/hg19 16p13.3(chr16:3772570-4156857)x3	copy number gain	not provided [RCV002474496]	Chr16:3772570..4156857 [GRCh37] Chr16:16p13.3	likely pathogenic
NM_001116.4(ADCY9):c.1763T>C (p.Leu588Pro)	single nucleotide variant	not specified [RCV004117162]	Chr16:4007489 [GRCh38] Chr16:4057490 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.1930G>A (p.Gly644Ser)	single nucleotide variant	not specified [RCV004080934]	Chr16:3993465 [GRCh38] Chr16:4043466 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.23A>G (p.Gln8Arg)	single nucleotide variant	not specified [RCV004169227]	Chr16:4115420 [GRCh38] Chr16:4165421 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.524C>T (p.Thr175Ile)	single nucleotide variant	not specified [RCV004101035]	Chr16:4114919 [GRCh38] Chr16:4164920 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.3709A>G (p.Met1237Val)	single nucleotide variant	not specified [RCV004083941]	Chr16:3966128 [GRCh38] Chr16:4016129 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2816T>C (p.Leu939Pro)	single nucleotide variant	not specified [RCV004192134]	Chr16:3977494 [GRCh38] Chr16:4027495 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.700C>T (p.Leu234Phe)	single nucleotide variant	not specified [RCV004134224]	Chr16:4114743 [GRCh38] Chr16:4164744 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.996G>T (p.Arg332Ser)	single nucleotide variant	not specified [RCV004106250]	Chr16:4114447 [GRCh38] Chr16:4164448 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.1019G>T (p.Arg340Ile)	single nucleotide variant	not specified [RCV004126046]	Chr16:4114424 [GRCh38] Chr16:4164425 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.3395A>G (p.Gln1132Arg)	single nucleotide variant	not specified [RCV004074002]	Chr16:3966442 [GRCh38] Chr16:4016443 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2845C>G (p.Pro949Ala)	single nucleotide variant	not specified [RCV004141757]	Chr16:3974694 [GRCh38] Chr16:4024695 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.643G>T (p.Asp215Tyr)	single nucleotide variant	not specified [RCV004218116]	Chr16:4114800 [GRCh38] Chr16:4164801 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.412A>C (p.Met138Leu)	single nucleotide variant	not specified [RCV004218581]	Chr16:4115031 [GRCh38] Chr16:4165032 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.935A>G (p.Lys312Arg)	single nucleotide variant	not specified [RCV004140809]	Chr16:4114508 [GRCh38] Chr16:4164509 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2288A>G (p.Tyr763Cys)	single nucleotide variant	not specified [RCV004153745]	Chr16:3989016 [GRCh38] Chr16:4039017 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2611A>C (p.Ile871Leu)	single nucleotide variant	not specified [RCV004115493]	Chr16:3979184 [GRCh38] Chr16:4029185 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2023G>A (p.Gly675Arg)	single nucleotide variant	not specified [RCV004209214]	Chr16:3992330 [GRCh38] Chr16:4042331 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2716G>A (p.Val906Ile)	single nucleotide variant	not specified [RCV004227348]	Chr16:3977594 [GRCh38] Chr16:4027595 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.1736C>T (p.Ser579Phe)	single nucleotide variant	not specified [RCV004214586]	Chr16:4007516 [GRCh38] Chr16:4057517 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.860T>C (p.Leu287Pro)	single nucleotide variant	not specified [RCV004135516]	Chr16:4114583 [GRCh38] Chr16:4164584 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2143C>G (p.Leu715Val)	single nucleotide variant	not specified [RCV004145996]	Chr16:3992210 [GRCh38] Chr16:4042211 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.3282G>C (p.Glu1094Asp)	single nucleotide variant	not specified [RCV004128910]	Chr16:3966555 [GRCh38] Chr16:4016556 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.3788G>A (p.Arg1263His)	single nucleotide variant	not specified [RCV004208981]	Chr16:3966049 [GRCh38] Chr16:4016050 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.716A>C (p.His239Pro)	single nucleotide variant	not specified [RCV004106928]	Chr16:4114727 [GRCh38] Chr16:4164728 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2437A>G (p.Thr813Ala)	single nucleotide variant	not specified [RCV004227847]	Chr16:3983314 [GRCh38] Chr16:4033315 [GRCh37] Chr16:16p13.3	likely benign
NM_001116.4(ADCY9):c.1214A>G (p.Lys405Arg)	single nucleotide variant	not specified [RCV004152215]	Chr16:4114229 [GRCh38] Chr16:4164230 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.1417A>G (p.Ile473Val)	single nucleotide variant	not specified [RCV004170602]	Chr16:4114026 [GRCh38] Chr16:4164027 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.3929G>T (p.Arg1310Ile)	single nucleotide variant	not specified [RCV004162958]	Chr16:3965908 [GRCh38] Chr16:4015909 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.656C>T (p.Ser219Phe)	single nucleotide variant	not specified [RCV004147091]	Chr16:4114787 [GRCh38] Chr16:4164788 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.1613A>G (p.Tyr538Cys)	single nucleotide variant	not specified [RCV004097171]	Chr16:4113830 [GRCh38] Chr16:4163831 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2629G>A (p.Ala877Thr)	single nucleotide variant	not specified [RCV004083469]	Chr16:3979166 [GRCh38] Chr16:4029167 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2741A>C (p.Gln914Pro)	single nucleotide variant	not specified [RCV004278049]	Chr16:3977569 [GRCh38] Chr16:4027570 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2821C>G (p.Pro941Ala)	single nucleotide variant	not specified [RCV004266772]	Chr16:3977489 [GRCh38] Chr16:4027490 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.1852G>A (p.Ala618Thr)	single nucleotide variant	not specified [RCV004280121]	Chr16:4007400 [GRCh38] Chr16:4057401 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.3962G>A (p.Arg1321Lys)	single nucleotide variant	not specified [RCV004329228]	Chr16:3965875 [GRCh38] Chr16:4015876 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.3800A>G (p.Asp1267Gly)	single nucleotide variant	not specified [RCV004344549]	Chr16:3966037 [GRCh38] Chr16:4016038 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.431T>G (p.Val144Gly)	single nucleotide variant	not specified [RCV004340123]	Chr16:4115012 [GRCh38] Chr16:4165013 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2705C>T (p.Ala902Val)	single nucleotide variant	not specified [RCV004358702]	Chr16:3977605 [GRCh38] Chr16:4027606 [GRCh37] Chr16:16p13.3	likely benign
NM_001116.4(ADCY9):c.3163G>T (p.Asp1055Tyr)	single nucleotide variant	not specified [RCV004359533]	Chr16:3966674 [GRCh38] Chr16:4016675 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.3382G>A (p.Gly1128Ser)	single nucleotide variant	not specified [RCV004359534]	Chr16:3966455 [GRCh38] Chr16:4016456 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.1787G>A (p.Gly596Asp)	single nucleotide variant	not specified [RCV004348168]	Chr16:4007465 [GRCh38] Chr16:4057466 [GRCh37] Chr16:16p13.3	uncertain significance
GRCh37/hg19 16p13.3(chr16:3792951-4274168)x3	copy number gain	not provided [RCV003485086]	Chr16:3792951..4274168 [GRCh37] Chr16:16p13.3	likely pathogenic
NM_001116.4(ADCY9):c.2898G>C (p.Ser966=)	single nucleotide variant	not provided [RCV003426562]	Chr16:3966939 [GRCh38] Chr16:4016940 [GRCh37] Chr16:16p13.3	likely benign
NM_001116.4(ADCY9):c.3493G>A (p.Val1165Ile)	single nucleotide variant	not provided [RCV003411254]	Chr16:3966344 [GRCh38] Chr16:4016345 [GRCh37] Chr16:16p13.3	likely benign
NM_001116.4(ADCY9):c.1578C>T (p.Ala526=)	single nucleotide variant	not provided [RCV003426563]	Chr16:4113865 [GRCh38] Chr16:4163866 [GRCh37] Chr16:16p13.3	likely benign
NM_001116.4(ADCY9):c.1609A>G (p.Lys537Glu)	single nucleotide variant	not specified [RCV004373731]	Chr16:4113834 [GRCh38] Chr16:4163835 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.1624C>T (p.Arg542Trp)	single nucleotide variant	not specified [RCV004373739]	Chr16:4113819 [GRCh38] Chr16:4163820 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2242A>G (p.Asn748Asp)	single nucleotide variant	not specified [RCV004373767]	Chr16:3989062 [GRCh38] Chr16:4039063 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2059A>C (p.Asn687His)	single nucleotide variant	not specified [RCV004373759]	Chr16:3992294 [GRCh38] Chr16:4042295 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2884C>A (p.Pro962Thr)	single nucleotide variant	not specified [RCV004373817]	Chr16:3966953 [GRCh38] Chr16:4016954 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.3437T>C (p.Met1146Thr)	single nucleotide variant	not specified [RCV004373863]	Chr16:3966400 [GRCh38] Chr16:4016401 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.344G>A (p.Arg115Gln)	single nucleotide variant	not specified [RCV004373869]	Chr16:4115099 [GRCh38] Chr16:4165100 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.3604G>A (p.Val1202Met)	single nucleotide variant	not specified [RCV004373877]	Chr16:3966233 [GRCh38] Chr16:4016234 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.578A>G (p.Gln193Arg)	single nucleotide variant	not specified [RCV004375877]	Chr16:4114865 [GRCh38] Chr16:4164866 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.1422G>T (p.Glu474Asp)	single nucleotide variant	not specified [RCV004373729]	Chr16:4114021 [GRCh38] Chr16:4164022 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2671A>G (p.Asn891Asp)	single nucleotide variant	not specified [RCV004373788]	Chr16:3979124 [GRCh38] Chr16:4029125 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2503C>T (p.Leu835Phe)	single nucleotide variant	not specified [RCV004373776]	Chr16:3983248 [GRCh38] Chr16:4033249 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.3844G>A (p.Val1282Met)	single nucleotide variant	not specified [RCV004373885]	Chr16:3965993 [GRCh38] Chr16:4015994 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2857G>C (p.Val953Leu)	single nucleotide variant	not specified [RCV004373808]	Chr16:3974682 [GRCh38] Chr16:4024683 [GRCh37] Chr16:16p13.3	uncertain significance
GRCh37/hg19 16p13.3(chr16:2990033-4837646)x1	copy number loss	not provided [RCV003885471]	Chr16:2990033..4837646 [GRCh37] Chr16:16p13.3	pathogenic
NM_001116.4(ADCY9):c.3936G>T (p.Trp1312Cys)	single nucleotide variant	not specified [RCV004373893]	Chr16:3965901 [GRCh38] Chr16:4015902 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2692A>G (p.Thr898Ala)	single nucleotide variant	not specified [RCV004613645]	Chr16:3977618 [GRCh38] Chr16:4027619 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2605G>A (p.Gly869Arg)	single nucleotide variant	not specified [RCV004613625]	Chr16:3979190 [GRCh38] Chr16:4029191 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.410A>G (p.His137Arg)	single nucleotide variant	not specified [RCV004613572]	Chr16:4115033 [GRCh38] Chr16:4165034 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.1261G>C (p.Asp421His)	single nucleotide variant	not specified [RCV004613614]	Chr16:4114182 [GRCh38] Chr16:4164183 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.589C>G (p.Pro197Ala)	single nucleotide variant	not specified [RCV004613565]	Chr16:4114854 [GRCh38] Chr16:4164855 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.3025C>G (p.His1009Asp)	single nucleotide variant	not specified [RCV004613593]	Chr16:3966812 [GRCh38] Chr16:4016813 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.818G>A (p.Gly273Glu)	single nucleotide variant	not specified [RCV004613583]	Chr16:4114625 [GRCh38] Chr16:4164626 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.1814G>A (p.Gly605Glu)	single nucleotide variant	not specified [RCV004613604]	Chr16:4007438 [GRCh38] Chr16:4057439 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.506C>A (p.Ala169Asp)	single nucleotide variant	not specified [RCV004613636]	Chr16:4114937 [GRCh38] Chr16:4164938 [GRCh37] Chr16:16p13.3	uncertain significance
GRCh37/hg19 16p13.3(chr16:3761912-4073514)x1	copy number loss	not provided [RCV004819385]	Chr16:3761912..4073514 [GRCh37] Chr16:16p13.3	pathogenic
GRCh37/hg19 16p13.3-13.13(chr16:85881-12268399)x3	copy number gain	not provided [RCV004819312]	Chr16:85881..12268399 [GRCh37] Chr16:16p13.3-13.13	pathogenic
GRCh37/hg19 16p13.3(chr16:513767-5555136)x3	copy number gain	not provided [RCV004819313]	Chr16:513767..5555136 [GRCh37] Chr16:16p13.3	pathogenic
NM_001116.4(ADCY9):c.2450C>T (p.Pro817Leu)	single nucleotide variant	not specified [RCV004907914]	Chr16:3983301 [GRCh38] Chr16:4033302 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2791C>T (p.Pro931Ser)	single nucleotide variant	not specified [RCV004907908]	Chr16:3977519 [GRCh38] Chr16:4027520 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2923G>A (p.Ala975Thr)	single nucleotide variant	not specified [RCV004907904]	Chr16:3966914 [GRCh38] Chr16:4016915 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.1684C>A (p.Gln562Lys)	single nucleotide variant	not specified [RCV004897555]	Chr16:4113759 [GRCh38] Chr16:4163760 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2776G>A (p.Val926Ile)	single nucleotide variant	not specified [RCV004897586]	Chr16:3977534 [GRCh38] Chr16:4027535 [GRCh37] Chr16:16p13.3	likely benign
NM_001116.4(ADCY9):c.635G>A (p.Arg212Gln)	single nucleotide variant	not specified [RCV004897534]	Chr16:4114808 [GRCh38] Chr16:4164809 [GRCh37] Chr16:16p13.3	likely benign
NM_001116.4(ADCY9):c.1936G>A (p.Glu646Lys)	single nucleotide variant	not specified [RCV004897545]	Chr16:3993459 [GRCh38] Chr16:4043460 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.864C>G (p.His288Gln)	single nucleotide variant	not specified [RCV004897605]	Chr16:4114579 [GRCh38] Chr16:4164580 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.1742G>C (p.Cys581Ser)	single nucleotide variant	not specified [RCV004907925]	Chr16:4007510 [GRCh38] Chr16:4057511 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2426A>G (p.Tyr809Cys)	single nucleotide variant	not specified [RCV004907913]	Chr16:3983325 [GRCh38] Chr16:4033326 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.3417C>G (p.Phe1139Leu)	single nucleotide variant	not specified [RCV004907916]	Chr16:3966420 [GRCh38] Chr16:4016421 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2371G>A (p.Val791Met)	single nucleotide variant	not specified [RCV004907915]	Chr16:3983380 [GRCh38] Chr16:4033381 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.3643G>C (p.Val1215Leu)	single nucleotide variant	not specified [RCV004907936]	Chr16:3966194 [GRCh38] Chr16:4016195 [GRCh37] Chr16:16p13.3	uncertain significance
NM_001116.4(ADCY9):c.2885C>A (p.Pro962Gln)	single nucleotide variant	not specified [RCV004897575]	Chr16:3966952 [GRCh38] Chr16:4016953 [GRCh37] Chr16:16p13.3	uncertain significance

miRNA Target Status (No longer updated)

Predicted Target Of

	Summary Value
Count of predictions:	2531
Count of miRNA genes:	1135
Interacting mature miRNAs:	1388
Transcripts:	ENST00000294016, ENST00000571467, ENST00000571889, ENST00000572288, ENST00000574721, ENST00000575550, ENST00000576936
Prediction methods:	Miranda, Rnahybrid
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

QTLs in Region (GRCh38)

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
597600671	GWAS1657531_H	body mass index QTL GWAS1657531 (human)		5e-23	body mass index	body mass index (BMI) (CMO:0000105)	16	3965728	3965729	Human
597382298	GWAS1478372_H	monocyte count QTL GWAS1478372 (human)		1e-20	monocyte quantity (VT:0000223)	blood monocyte count (CMO:0000032)	16	4015582	4015583	Human
597064596	GWAS1160670_H	body mass index QTL GWAS1160670 (human)		9e-10	body mass index	body mass index (BMI) (CMO:0000105)	16	3963466	3963467	Human
597348505	GWAS1444579_H	lean body mass QTL GWAS1444579 (human)		4e-27	body lean mass (VT:0010483)	total body lean mass (CMO:0003950)	16	3965728	3965729	Human
406940487	GWAS589463_H	heel bone mineral density QTL GWAS589463 (human)		7e-20	heel bone mineral density	bone mineral density (CMO:0001226)	16	3964963	3964964	Human
597318034	GWAS1414108_H	diastolic blood pressure QTL GWAS1414108 (human)		1e-10	diastolic blood pressure	diastolic blood pressure (CMO:0000005)	16	4088377	4088378	Human
597331859	GWAS1427933_H	body mass index QTL GWAS1427933 (human)		2e-24	body mass index	body mass index (BMI) (CMO:0000105)	16	3965728	3965729	Human
597104029	GWAS1200103_H	platelet count QTL GWAS1200103 (human)		1e-09	platelet quantity (VT:0003179)	platelet count (CMO:0000029)	16	3998019	3998020	Human
597231762	GWAS1327836_H	body mass index QTL GWAS1327836 (human)		4e-14	body mass index	body mass index (BMI) (CMO:0000105)	16	3965728	3965729	Human
597304721	GWAS1400795_H	monocyte count QTL GWAS1400795 (human)		5e-16	monocyte quantity (VT:0000223)	blood monocyte count (CMO:0000032)	16	4016890	4016891	Human
597064603	GWAS1160677_H	physical activity measurement, body mass index QTL GWAS1160677 (human)		5e-11	wellness/fitness trait (VT:1000152)	body mass index (BMI) (CMO:0000105)	16	3963466	3963467	Human
597082777	GWAS1178851_H	lymphocyte count QTL GWAS1178851 (human)		1e-17	lymphocyte count	blood lymphocyte count (CMO:0000031)	16	4098239	4098240	Human
597266312	GWAS1362386_H	body mass index QTL GWAS1362386 (human)		0.0000009	body mass index	body mass index (BMI) (CMO:0000105)	16	3965728	3965729	Human
597374601	GWAS1470675_H	mean corpuscular hemoglobin concentration QTL GWAS1470675 (human)		1e-09	mean corpuscular hemoglobin concentration	mean corpuscular hemoglobin concentration (CMO:0000291)	16	3959763	3959764	Human
597618827	GWAS1675687_H	body weight QTL GWAS1675687 (human)		3e-35	body mass (VT:0001259)	body weight (CMO:0000012)	16	3964281	3964282	Human
597065345	GWAS1161419_H	body mass index QTL GWAS1161419 (human)		8e-10	body mass index	body mass index (BMI) (CMO:0000105)	16	3963466	3963467	Human
597322381	GWAS1418455_H	high density lipoprotein cholesterol measurement QTL GWAS1418455 (human)		3e-09	high density lipoprotein cholesterol measurement	blood high density lipoprotein cholesterol level (CMO:0000052)	16	3964281	3964282	Human
596969097	GWAS1088616_H	systolic blood pressure QTL GWAS1088616 (human)		2e-12	systolic blood pressure		16	4091126	4091127	Human
597270151	GWAS1366225_H	diastolic blood pressure QTL GWAS1366225 (human)		4e-09	diastolic blood pressure	diastolic blood pressure (CMO:0000005)	16	3965045	3965046	Human
597580673	GWAS1637533_H	morbid obesity QTL GWAS1637533 (human)		2e-17	morbid obesity		16	3965728	3965729	Human
407304537	GWAS953513_H	lymphocyte count QTL GWAS953513 (human)		6e-19	lymphocyte count	blood lymphocyte count (CMO:0000031)	16	4098239	4098240	Human
597019828	GWAS1115902_H	body mass index QTL GWAS1115902 (human)		9e-15	body mass index	body mass index (BMI) (CMO:0000105)	16	3963466	3963467	Human
597291195	GWAS1387269_H	body mass index QTL GWAS1387269 (human)		1e-20	body mass index	body mass index (BMI) (CMO:0000105)	16	3965728	3965729	Human
407044705	GWAS693681_H	body mass index QTL GWAS693681 (human)		3e-17	body mass index	body mass index (BMI) (CMO:0000105)	16	3993174	3993175	Human
597371327	GWAS1467401_H	monocyte count QTL GWAS1467401 (human)		1e-30	monocyte quantity (VT:0000223)	blood monocyte count (CMO:0000032)	16	4015582	4015583	Human
597581499	GWAS1638359_H	monocyte count QTL GWAS1638359 (human)		8e-13	monocyte quantity (VT:0000223)	blood monocyte count (CMO:0000032)	16	4016890	4016891	Human
597422526	GWAS1518600_H	systolic blood pressure QTL GWAS1518600 (human)		1e-10	systolic blood pressure	systolic blood pressure (CMO:0000004)	16	4091126	4091127	Human
597422525	GWAS1518599_H	systolic blood pressure QTL GWAS1518599 (human)		3e-08	systolic blood pressure	systolic blood pressure (CMO:0000004)	16	3988527	3988528	Human
597422524	GWAS1518598_H	systolic blood pressure QTL GWAS1518598 (human)		4e-11	systolic blood pressure	systolic blood pressure (CMO:0000004)	16	3965045	3965046	Human
597024434	GWAS1120508_H	estrogen-receptor negative breast cancer QTL GWAS1120508 (human)		2e-08	estrogen-receptor negative breast cancer		16	4056787	4056788	Human
597589433	GWAS1646293_H	monocyte count QTL GWAS1646293 (human)		2e-14	monocyte quantity (VT:0000223)	blood monocyte count (CMO:0000032)	16	4074107	4074108	Human
596966844	GWAS1086363_H	diastolic blood pressure QTL GWAS1086363 (human)		1e-10	diastolic blood pressure		16	4088377	4088378	Human
597606324	GWAS1663184_H	obesity QTL GWAS1663184 (human)		5e-14	obesity		16	3964281	3964282	Human
597065405	GWAS1161479_H	physical activity measurement, body mass index QTL GWAS1161479 (human)		2e-11	wellness/fitness trait (VT:1000152)	body mass index (BMI) (CMO:0000105)	16	3963466	3963467	Human
597196979	GWAS1293053_H	body mass index QTL GWAS1293053 (human)		2e-13	body mass index	body mass index (BMI) (CMO:0000105)	16	3972234	3972235	Human
596955071	GWAS1074590_H	Red cell distribution width QTL GWAS1074590 (human)		2e-08	Red cell distribution width		16	3972702	3972703	Human
597239733	GWAS1335807_H	appendicular lean mass QTL GWAS1335807 (human)		2e-19	appendicular lean mass		16	3965315	3965316	Human
597242548	GWAS1338622_H	body fat percentage QTL GWAS1338622 (human)		1e-19	body fat mass (VT:0010482)	body fat percentage (CMO:0000302)	16	3965728	3965729	Human
597202344	GWAS1298418_H	diastolic blood pressure QTL GWAS1298418 (human)		3e-17	diastolic blood pressure	diastolic blood pressure (CMO:0000005)	16	3970731	3970732	Human
597202345	GWAS1298419_H	diastolic blood pressure QTL GWAS1298419 (human)		2e-10	diastolic blood pressure	diastolic blood pressure (CMO:0000005)	16	4091126	4091127	Human
597064356	GWAS1160430_H	physical activity measurement, body mass index QTL GWAS1160430 (human)		0.000006	wellness/fitness trait (VT:1000152)	body mass index (BMI) (CMO:0000105)	16	3963466	3963467	Human
407095153	GWAS744129_H	body fat percentage QTL GWAS744129 (human)		0.000003	body fat mass (VT:0010482)	body fat percentage (CMO:0000302)	16	3965728	3965729	Human
597062306	GWAS1158380_H	body mass index QTL GWAS1158380 (human)		0.0000006	body mass index	body mass index (BMI) (CMO:0000105)	16	3963466	3963467	Human
596967074	GWAS1086593_H	body mass index QTL GWAS1086593 (human)		4e-31	body mass index		16	3965728	3965729	Human
597026723	GWAS1122797_H	body mass index QTL GWAS1122797 (human)		2e-16	body mass index	body mass index (BMI) (CMO:0000105)	16	3972702	3972703	Human
597149856	GWAS1245930_H	body mass index QTL GWAS1245930 (human)		3e-39	body mass index	body mass index (BMI) (CMO:0000105)	16	3965728	3965729	Human
407223676	GWAS872652_H	lymphocyte count QTL GWAS872652 (human)		8e-09	lymphocyte count	blood lymphocyte count (CMO:0000031)	16	4070075	4070076	Human
597087916	GWAS1183990_H	monocyte percentage of leukocytes QTL GWAS1183990 (human)		1e-12	monocyte quantity (VT:0000223)	blood monocyte count to total leukocyte count ratio (CMO:0000374)	16	4091727	4091728	Human
406922106	GWAS571082_H	lean body mass QTL GWAS571082 (human)		1e-09	body lean mass (VT:0010483)	total body lean mass (CMO:0003950)	16	3963466	3963467	Human
596953257	GWAS1072776_H	size QTL GWAS1072776 (human)		7e-12	size		16	3969349	3969350	Human
597087915	GWAS1183989_H	monocyte percentage of leukocytes QTL GWAS1183989 (human)		3e-16	monocyte quantity (VT:0000223)	blood monocyte count to total leukocyte count ratio (CMO:0000374)	16	4012435	4012436	Human
597024471	GWAS1120545_H	breast carcinoma QTL GWAS1120545 (human)		1e-08	mammary gland integrity trait (VT:0010552)		16	4056787	4056788	Human
597060563	GWAS1156637_H	metabolic syndrome QTL GWAS1156637 (human)		9e-29	metabolic syndrome		16	3965728	3965729	Human
597033171	GWAS1129245_H	body fat percentage QTL GWAS1129245 (human)		1e-10	body fat mass (VT:0010482)	body fat percentage (CMO:0000302)	16	3965728	3965729	Human
597129682	GWAS1225756_H	sex interaction measurement, cerebral amyloid angiopathy QTL GWAS1225756 (human)		0.000009	sex interaction measurement, cerebral amyloid angiopathy		16	4022014	4022015	Human
407022347	GWAS671323_H	obesity QTL GWAS671323 (human)		4e-08	obesity		16	3963466	3963467	Human
597293527	GWAS1389601_H	body mass index QTL GWAS1389601 (human)		4e-35	body mass index	body mass index (BMI) (CMO:0000105)	16	3965728	3965729	Human
597614800	GWAS1671660_H	Red cell distribution width QTL GWAS1671660 (human)		5e-12	Red cell distribution width	red blood cell distribution width- standard deviation (CMO:0003232)	16	4031137	4031138	Human
597241046	GWAS1337120_H	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement QTL GWAS1337120 (human)		7e-17	body fat mass (VT:0010482)	blood high density lipoprotein cholesterol level (CMO:0000052)	16	3965728	3965729	Human
597157829	GWAS1253903_H	testosterone measurement QTL GWAS1253903 (human)		3e-09	testosterone measurement	serum testosterone level (CMO:0000568)	16	4106422	4106423	Human
597594314	GWAS1651174_H	body mass index QTL GWAS1651174 (human)		1e-47	body mass index	body mass index (BMI) (CMO:0000105)	16	3965728	3965729	Human
596976320	GWAS1095839_H	hypertension QTL GWAS1095839 (human)		1e-11	hypertension		16	4091126	4091127	Human
597144512	GWAS1240586_H	Antihypertensive use measurement QTL GWAS1240586 (human)		2e-09	Agents acting on the renin-angiotensin system use measurement		16	3970731	3970732	Human
597601222	GWAS1658082_H	body mass index QTL GWAS1658082 (human)		6e-25	body mass index	body mass index (BMI) (CMO:0000105)	16	3965728	3965729	Human
597106636	GWAS1202710_H	testosterone measurement QTL GWAS1202710 (human)		3e-10	testosterone measurement	serum testosterone level (CMO:0000568)	16	4085561	4085562	Human
597106635	GWAS1202709_H	testosterone measurement QTL GWAS1202709 (human)		1e-09	testosterone measurement	serum testosterone level (CMO:0000568)	16	3965045	3965046	Human
597612992	GWAS1669852_H	erythrocyte count QTL GWAS1669852 (human)		6e-15	erythrocyte count	red blood cell count (CMO:0000025)	16	4029822	4029823	Human
597601729	GWAS1658589_H	monocyte count QTL GWAS1658589 (human)		1e-11	monocyte quantity (VT:0000223)	blood monocyte count (CMO:0000032)	16	4074107	4074108	Human
597219833	GWAS1315907_H	glucose measurement QTL GWAS1315907 (human)		4e-09	glucose measurement	blood glucose level (CMO:0000046)	16	3964281	3964282	Human
597607929	GWAS1664789_H	body weight QTL GWAS1664789 (human)		3e-44	body mass (VT:0001259)	body weight (CMO:0000012)	16	3963466	3963467	Human
597166835	GWAS1262909_H	body weight QTL GWAS1262909 (human)		1e-14	body mass (VT:0001259)	body weight (CMO:0000012)	16	3965728	3965729	Human
597097978	GWAS1194052_H	comparative body size at age 10, self-reported QTL GWAS1194052 (human)		3e-30	comparative body size at age 10, self-reported		16	3964281	3964282	Human
597612274	GWAS1669134_H	body weight QTL GWAS1669134 (human)		2e-91	body mass (VT:0001259)	body weight (CMO:0000012)	16	3965728	3965729	Human
597053434	GWAS1149508_H	cardiovascular disease QTL GWAS1149508 (human)		3e-10	cardiovascular disease		16	4087261	4087262	Human
597347829	GWAS1443903_H	systolic blood pressure QTL GWAS1443903 (human)		2e-11	systolic blood pressure	systolic blood pressure (CMO:0000004)	16	4091126	4091127	Human
597190391	GWAS1286465_H	testosterone measurement QTL GWAS1286465 (human)		6e-09	testosterone measurement	serum testosterone level (CMO:0000568)	16	4106808	4106809	Human
597589487	GWAS1646347_H	monocyte count QTL GWAS1646347 (human)		2e-12	monocyte quantity (VT:0000223)	blood monocyte count (CMO:0000032)	16	4016890	4016891	Human
597609708	GWAS1666568_H	body weight QTL GWAS1666568 (human)		4e-96	body mass (VT:0001259)	body weight (CMO:0000012)	16	3965728	3965729	Human
407382844	GWAS1031820_H	obsolete_red blood cell distribution width QTL GWAS1031820 (human)		2e-08	obsolete_red blood cell distribution width		16	3972702	3972703	Human
597283820	GWAS1379894_H	C-reactive protein measurement QTL GWAS1379894 (human)		2e-09	C-reactive protein measurement	blood uric acid level (CMO:0000501)	16	3965728	3965729	Human
597582308	GWAS1639168_H	amyloid-beta measurement QTL GWAS1639168 (human)		0.000006	amyloid-beta measurement		16	3959121	3959122	Human
597620448	GWAS1677308_H	body weight QTL GWAS1677308 (human)		4e-22	body mass (VT:0001259)	body weight (CMO:0000012)	16	3963466	3963467	Human
597492194	GWAS1588268_H	body mass index QTL GWAS1588268 (human)		3e-08	body mass index	body mass index (BMI) (CMO:0000105)	16	3955520	3955521	Human
597054486	GWAS1150560_H	systolic blood pressure QTL GWAS1150560 (human)		8e-10	systolic blood pressure	systolic blood pressure (CMO:0000004)	16	4091126	4091127	Human
597317145	GWAS1413219_H	body surface area QTL GWAS1413219 (human)		9e-32	body surface area		16	3965728	3965729	Human
597043219	GWAS1139293_H	heel bone mineral density QTL GWAS1139293 (human)		1e-08	heel bone mineral density	bone mineral density (CMO:0001226)	16	3971733	3971734	Human
597601304	GWAS1658164_H	body mass index QTL GWAS1658164 (human)		2e-24	body mass index	body mass index (BMI) (CMO:0000105)	16	3964281	3964282	Human
597096209	GWAS1192283_H	testosterone measurement QTL GWAS1192283 (human)		4e-24	testosterone measurement	serum testosterone level (CMO:0000568)	16	4106422	4106423	Human
597023003	GWAS1119077_H	breast carcinoma QTL GWAS1119077 (human)		0.000001	mammary gland integrity trait (VT:0010552)		16	4058157	4058158	Human
597190166	GWAS1286240_H	testosterone measurement QTL GWAS1286240 (human)		2e-12	testosterone measurement	serum testosterone level (CMO:0000568)	16	4106808	4106809	Human
407027666	GWAS676642_H	partial epilepsy QTL GWAS676642 (human)		0.000001	partial epilepsy		16	4053870	4053871	Human
407226836	GWAS875812_H	asthma, response to diisocyanate QTL GWAS875812 (human)		0.000002	asthma, response to diisocyanate		16	4021721	4021722	Human
597134340	GWAS1230414_H	body weight QTL GWAS1230414 (human)		1e-14	body mass (VT:0001259)	body weight (CMO:0000012)	16	3967391	3967392	Human
597589261	GWAS1646121_H	monocyte count QTL GWAS1646121 (human)		2e-11	monocyte quantity (VT:0000223)	blood monocyte count (CMO:0000032)	16	4016890	4016891	Human
597033733	GWAS1129807_H	systolic blood pressure QTL GWAS1129807 (human)		3e-08	systolic blood pressure	systolic blood pressure (CMO:0000004)	16	4078852	4078853	Human
597602826	GWAS1659686_H	monocyte count QTL GWAS1659686 (human)		1e-21	monocyte quantity (VT:0000223)	blood monocyte count (CMO:0000032)	16	4074107	4074108	Human
597062403	GWAS1158477_H	physical activity measurement, body mass index QTL GWAS1158477 (human)		0.000001	wellness/fitness trait (VT:1000152)	body mass index (BMI) (CMO:0000105)	16	3963466	3963467	Human
597176590	GWAS1272664_H	body mass index QTL GWAS1272664 (human)		9e-57	body mass index	body mass index (BMI) (CMO:0000105)	16	3965728	3965729	Human
597176591	GWAS1272665_H	body mass index QTL GWAS1272665 (human)		2e-11	body mass index	body mass index (BMI) (CMO:0000105)	16	3987393	3987394	Human
597375489	GWAS1471563_H	body mass index QTL GWAS1471563 (human)		1e-10	body mass index	body mass index (BMI) (CMO:0000105)	16	3956162	3956163	Human
597070604	GWAS1166678_H	body weight QTL GWAS1166678 (human)		1e-08	body mass (VT:0001259)	body weight (CMO:0000012)	16	3963466	3963467	Human
597329920	GWAS1425994_H	sexual dimorphism measurement QTL GWAS1425994 (human)		4e-14	sexual dimorphism measurement		16	3964281	3964282	Human
596976655	GWAS1096174_H	body height QTL GWAS1096174 (human)		9e-31	body height		16	3969349	3969350	Human
597329921	GWAS1425995_H	sexual dimorphism measurement QTL GWAS1425995 (human)		1e-08	sexual dimorphism measurement		16	3977604	3977605	Human
597100041	GWAS1196115_H	gut microbiome measurement QTL GWAS1196115 (human)		0.000006	gut microbiome measurement		16	3999839	3999840	Human
596967477	GWAS1086996_H	diastolic blood pressure QTL GWAS1086996 (human)		5e-16	diastolic blood pressure		16	3970731	3970732	Human
597074997	GWAS1171071_H	body mass index QTL GWAS1171071 (human)		3e-12	body mass index	body mass index (BMI) (CMO:0000105)	16	3972693	3972694	Human
597378366	GWAS1474440_H	response to dalcetrapib, cardiovascular event measurement QTL GWAS1474440 (human)		2e-08	response to dalcetrapib, cardiovascular event measurement	cardiovascular measurement (CMO:0000001)	16	4015582	4015583	Human
597375549	GWAS1471623_H	monocyte count QTL GWAS1471623 (human)		4e-29	monocyte quantity (VT:0000223)	blood monocyte count (CMO:0000032)	16	4015582	4015583	Human
597050673	GWAS1146747_H	Red cell distribution width QTL GWAS1146747 (human)		2e-08	Red cell distribution width	red blood cell distribution width- standard deviation (CMO:0003232)	16	3972702	3972703	Human
406916841	GWAS565817_H	lean body mass QTL GWAS565817 (human)		0.0000003	body lean mass (VT:0010483)	total body lean mass (CMO:0003950)	16	3963466	3963467	Human
597062207	GWAS1158281_H	physical activity measurement, body mass index QTL GWAS1158281 (human)		0.0000005	wellness/fitness trait (VT:1000152)	body mass index (BMI) (CMO:0000105)	16	3963466	3963467	Human
597285174	GWAS1381248_H	body weight QTL GWAS1381248 (human)		8e-45	body mass (VT:0001259)	body weight (CMO:0000012)	16	3965728	3965729	Human
597424425	GWAS1520499_H	blood phosphate measurement QTL GWAS1520499 (human)		9e-13	blood phosphate amount (VT:0001565)	blood phosphate level (CMO:0000504)	16	3982580	3982581	Human
407114999	GWAS763975_H	body fat percentage QTL GWAS763975 (human)		0.000009	body fat mass (VT:0010482)	body fat percentage (CMO:0000302)	16	3965728	3965729	Human
597311273	GWAS1407347_H	body mass index QTL GWAS1407347 (human)		8e-09	body mass index	body mass index (BMI) (CMO:0000105)	16	3965728	3965729	Human
597065506	GWAS1161580_H	physical activity measurement, body mass index QTL GWAS1161580 (human)		1e-11	wellness/fitness trait (VT:1000152)	body mass index (BMI) (CMO:0000105)	16	3963466	3963467	Human
597346093	GWAS1442167_H	body mass index QTL GWAS1442167 (human)		8e-24	body mass index	body mass index (BMI) (CMO:0000105)	16	3964281	3964282	Human
407047418	GWAS696394_H	body mass index QTL GWAS696394 (human)		9e-08	body mass index	body mass index (BMI) (CMO:0000105)	16	3988386	3988387	Human
597131308	GWAS1227382_H	pulse pressure measurement QTL GWAS1227382 (human)		0.000006	pulse pressure measurement	pulse pressure (CMO:0000292)	16	4091126	4091127	Human
597292836	GWAS1388910_H	hypertension QTL GWAS1388910 (human)		1e-10	hypertension		16	3965045	3965046	Human
597618209	GWAS1675069_H	bile duct disorder QTL GWAS1675069 (human)		5e-12	bile duct disorder		16	3978561	3978562	Human
597594204	GWAS1651064_H	body mass index QTL GWAS1651064 (human)		1e-71	body mass index	body mass index (BMI) (CMO:0000105)	16	3965728	3965729	Human
597313630	GWAS1409704_H	diastolic blood pressure QTL GWAS1409704 (human)		5e-16	diastolic blood pressure	diastolic blood pressure (CMO:0000005)	16	3970731	3970732	Human
597603672	GWAS1660532_H	monocyte count QTL GWAS1660532 (human)		1e-15	monocyte quantity (VT:0000223)	blood monocyte count (CMO:0000032)	16	4016890	4016891	Human
596953427	GWAS1072946_H	body mass index QTL GWAS1072946 (human)		1e-20	body mass index		16	3965728	3965729	Human
407174284	GWAS823260_H	body mass index QTL GWAS823260 (human)		1e-09	body mass index	body mass index (BMI) (CMO:0000105)	16	3970731	3970732	Human
407039627	GWAS688603_H	body mass index QTL GWAS688603 (human)		7e-08	body mass index	body mass index (BMI) (CMO:0000105)	16	3963466	3963467	Human
597605719	GWAS1662579_H	overnutrition, obesity QTL GWAS1662579 (human)		8e-12	overnutrition, obesity		16	3964281	3964282	Human
597075551	GWAS1171625_H	body mass index QTL GWAS1171625 (human)		9e-19	body mass index	body mass index (BMI) (CMO:0000105)	16	3965728	3965729	Human
597579092	GWAS1635952_H	overnutrition, obesity QTL GWAS1635952 (human)		9e-18	overnutrition, obesity		16	3964281	3964282	Human
597318992	GWAS1415066_H	body mass index QTL GWAS1415066 (human)		5e-11	body mass index	body mass index (BMI) (CMO:0000105)	16	3964281	3964282	Human
597347664	GWAS1443738_H	body fat percentage QTL GWAS1443738 (human)		8e-09	body fat mass (VT:0010482)	body fat percentage (CMO:0000302)	16	3965312	3965313	Human
597033309	GWAS1129383_H	lean body mass QTL GWAS1129383 (human)		9e-14	body lean mass (VT:0010483)	total body lean mass (CMO:0003950)	16	3963466	3963467	Human
597327958	GWAS1424032_H	body mass index QTL GWAS1424032 (human)		2e-31	body mass index	body mass index (BMI) (CMO:0000105)	16	3965728	3965729	Human
597610067	GWAS1666927_H	monocyte count QTL GWAS1666927 (human)		2e-15	monocyte quantity (VT:0000223)	blood monocyte count (CMO:0000032)	16	4074107	4074108	Human
597200983	GWAS1297057_H	systolic blood pressure QTL GWAS1297057 (human)		1e-14	systolic blood pressure	systolic blood pressure (CMO:0000004)	16	3970731	3970732	Human
596961860	GWAS1081379_H	metabolic syndrome QTL GWAS1081379 (human)		9e-29	metabolic syndrome		16	3965728	3965729	Human
597078342	GWAS1174416_H	lymphocyte percentage of leukocytes QTL GWAS1174416 (human)		5e-11	lymphocyte quantity (VT:0000717)	blood lymphocyte count to total leukocyte count ratio (CMO:0000371)	16	4111792	4111793	Human
597064772	GWAS1160846_H	body mass index QTL GWAS1160846 (human)		0.000003	body mass index	body mass index (BMI) (CMO:0000105)	16	3963466	3963467	Human
597290826	GWAS1386900_H	size QTL GWAS1386900 (human)		7e-12	size		16	3969349	3969350	Human
597617483	GWAS1674343_H	body weight QTL GWAS1674343 (human)		2e-35	body mass (VT:0001259)	body weight (CMO:0000012)	16	3964281	3964282	Human
596967233	GWAS1086752_H	body mass index QTL GWAS1086752 (human)		4e-35	body mass index		16	3965728	3965729	Human
597288780	GWAS1384854_H	hypertension QTL GWAS1384854 (human)		1e-11	hypertension		16	4091126	4091127	Human
597322319	GWAS1418393_H	systolic blood pressure QTL GWAS1418393 (human)		2e-12	systolic blood pressure	systolic blood pressure (CMO:0000004)	16	4091126	4091127	Human
597026627	GWAS1122701_H	body mass index QTL GWAS1122701 (human)		2e-31	body mass index	body mass index (BMI) (CMO:0000105)	16	3964281	3964282	Human
597033024	GWAS1129098_H	heel bone mineral density QTL GWAS1129098 (human)		5e-27	heel bone mineral density	bone mineral density (CMO:0001226)	16	3971733	3971734	Human
597167684	GWAS1263758_H	body mass index QTL GWAS1263758 (human)		6e-12	urate measurement	blood uric acid level (CMO:0000501)	16	3965728	3965729	Human
597098314	GWAS1194388_H	testosterone measurement QTL GWAS1194388 (human)		3e-12	testosterone measurement	serum testosterone level (CMO:0000568)	16	4107695	4107696	Human
597318779	GWAS1414853_H	body fat percentage QTL GWAS1414853 (human)		2e-08	body fat mass (VT:0010482)	body fat percentage (CMO:0000302)	16	3964281	3964282	Human
597226618	GWAS1322692_H	heel bone mineral density QTL GWAS1322692 (human)		3e-19	heel bone mineral density	bone mineral density (CMO:0001226)	16	3964963	3964964	Human
597064309	GWAS1160383_H	physical activity measurement, body mass index QTL GWAS1160383 (human)		3e-11	wellness/fitness trait (VT:1000152)	body mass index (BMI) (CMO:0000105)	16	3963466	3963467	Human
597271162	GWAS1367236_H	body mass index QTL GWAS1367236 (human)		4e-09	body mass index	body mass index (BMI) (CMO:0000105)	16	3965728	3965729	Human
597333374	GWAS1429448_H	R-6-hydroxywarfarin to R-warfarin ratio measurement QTL GWAS1429448 (human)		0.000002	R-6-hydroxywarfarin to R-warfarin ratio measurement		16	4056785	4056786	Human
597064563	GWAS1160637_H	physical activity measurement, body mass index QTL GWAS1160637 (human)		0.000005	wellness/fitness trait (VT:1000152)	body mass index (BMI) (CMO:0000105)	16	3963466	3963467	Human
597113201	GWAS1209275_H	body mass index QTL GWAS1209275 (human)		5e-09	body mass index	body mass index (BMI) (CMO:0000105)	16	3963466	3963467	Human
596957566	GWAS1077085_H	body mass index QTL GWAS1077085 (human)		0.000001	body mass index		16	3963466	3963467	Human
597621108	GWAS1677968_H	body weight QTL GWAS1677968 (human)		4e-33	body mass (VT:0001259)	body weight (CMO:0000012)	16	3964281	3964282	Human
597594229	GWAS1651089_H	body mass index QTL GWAS1651089 (human)		8e-67	body mass index	body mass index (BMI) (CMO:0000105)	16	3965728	3965729	Human
597287542	GWAS1383616_H	body mass index QTL GWAS1383616 (human)		6e-35	body mass index	body mass index (BMI) (CMO:0000105)	16	3965728	3965729	Human
597344629	GWAS1440703_H	urate measurement QTL GWAS1440703 (human)		2e-08	urate measurement	blood uric acid level (CMO:0000501)	16	3965728	3965729	Human
597578351	GWAS1635211_H	obesity QTL GWAS1635211 (human)		7e-24	obesity		16	3964281	3964282	Human
597608557	GWAS1665417_H	body weight QTL GWAS1665417 (human)		3e-69	body mass (VT:0001259)	body weight (CMO:0000012)	16	3963466	3963467	Human
407216817	GWAS865793_H	lymphocyte count QTL GWAS865793 (human)		2e-17	lymphocyte count	blood lymphocyte count (CMO:0000031)	16	4098239	4098240	Human
596952161	GWAS1071680_H	hypertension QTL GWAS1071680 (human)		1e-10	hypertension		16	3965045	3965046	Human
597315180	GWAS1411254_H	uric acid measurement QTL GWAS1411254 (human)		3e-09	uric acid measurement	blood uric acid level (CMO:0000501)	16	3972693	3972694	Human
597149039	GWAS1245113_H	body mass index QTL GWAS1245113 (human)		1e-08	body mass index	body mass index (BMI) (CMO:0000105)	16	4106422	4106423	Human
597149038	GWAS1245112_H	body mass index QTL GWAS1245112 (human)		9e-14	body mass index	body mass index (BMI) (CMO:0000105)	16	3992448	3992449	Human
597581159	GWAS1638019_H	monocyte count QTL GWAS1638019 (human)		6e-23	monocyte quantity (VT:0000223)	blood monocyte count (CMO:0000032)	16	4016890	4016891	Human
597149037	GWAS1245111_H	body mass index QTL GWAS1245111 (human)		2e-08	body mass index	body mass index (BMI) (CMO:0000105)	16	3987393	3987394	Human
597316198	GWAS1412272_H	body mass index QTL GWAS1412272 (human)		4e-31	body mass index	body mass index (BMI) (CMO:0000105)	16	3965728	3965729	Human
597461088	GWAS1557162_H	diastolic blood pressure QTL GWAS1557162 (human)		7e-14	diastolic blood pressure	diastolic blood pressure (CMO:0000005)	16	3970731	3970732	Human
597038442	GWAS1134516_H	gut microbiome measurement QTL GWAS1134516 (human)		0.000003	gut microbiome measurement		16	4026135	4026136	Human
597461089	GWAS1557163_H	diastolic blood pressure QTL GWAS1557163 (human)		3e-09	diastolic blood pressure	diastolic blood pressure (CMO:0000005)	16	4046510	4046511	Human
597089387	GWAS1185461_H	monocyte count QTL GWAS1185461 (human)		1e-10	monocyte quantity (VT:0000223)	blood monocyte count (CMO:0000032)	16	4077080	4077082	Human
597028458	GWAS1124532_H	body mass index QTL GWAS1124532 (human)		3e-17	body mass index	body mass index (BMI) (CMO:0000105)	16	3985067	3985068	Human

Markers in Region

D16S3027

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	14	80,185,400 - 80,185,892	UniSTS	GRCh37
GRCh37	16	4,050,872 - 4,051,137	UniSTS	GRCh37
Build 36	16	3,990,873 - 3,991,138	RGD	NCBI36
Celera	14	60,223,601 - 60,224,093	UniSTS
Celera	16	4,257,540 - 4,257,811	RGD
Cytogenetic Map	14	q31	UniSTS
Cytogenetic Map	16	pter-p13	UniSTS
Cytogenetic Map	16	p13.3	UniSTS
HuRef	16	4,019,215 - 4,019,484	UniSTS
Marshfield Genetic Map	16	8.71	UniSTS
Marshfield Genetic Map	16	8.71	RGD
Genethon Genetic Map	16	6.7	UniSTS
deCODE Assembly Map	16	10.46	UniSTS

RH64918

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	16	4,143,891 - 4,144,067	UniSTS	GRCh37
Build 36	16	4,083,892 - 4,084,068	RGD	NCBI36
Celera	16	4,350,595 - 4,350,771	RGD
Cytogenetic Map	16	p13.3	UniSTS
HuRef	16	4,112,008 - 4,112,184	UniSTS

RH47122

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	16	4,130,751 - 4,130,863	UniSTS	GRCh37
Build 36	16	4,070,752 - 4,070,864	RGD	NCBI36
Celera	16	4,337,455 - 4,337,567	RGD
Cytogenetic Map	16	p13.3	UniSTS
HuRef	16	4,098,868 - 4,098,980	UniSTS

RH102020

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	16	4,015,100 - 4,015,248	UniSTS	GRCh37
Build 36	16	3,955,101 - 3,955,249	RGD	NCBI36
Celera	16	4,221,748 - 4,221,896	RGD
Cytogenetic Map	16	p13.3	UniSTS
HuRef	16	3,983,456 - 3,983,604	UniSTS
GeneMap99-GB4 RH Map	16	68.88	UniSTS

G60525

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	16	4,050,870 - 4,051,134	UniSTS	GRCh37
Build 36	16	3,990,871 - 3,991,135	RGD	NCBI36
Celera	16	4,257,538 - 4,257,808	RGD
Cytogenetic Map	16	p13.3	UniSTS
HuRef	16	4,019,213 - 4,019,481	UniSTS
TNG Radiation Hybrid Map	16	2465.0	UniSTS
TNG Radiation Hybrid Map	3	34684.0	UniSTS

RH15630

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	16	4,012,730 - 4,012,903	UniSTS	GRCh37
Build 36	16	3,952,731 - 3,952,904	RGD	NCBI36
Celera	16	4,219,400 - 4,219,573	RGD
Cytogenetic Map	16	p13.3	UniSTS
HuRef	16	3,981,108 - 3,981,281	UniSTS
GeneMap99-GB4 RH Map	16	62.5	UniSTS

ADCY9_213

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	16	4,014,778 - 4,015,627	UniSTS	GRCh37
Build 36	16	3,954,779 - 3,955,628	RGD	NCBI36
Celera	16	4,221,426 - 4,222,275	RGD
HuRef	16	3,983,134 - 3,983,983	UniSTS

D16S3328

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	16	4,161,975 - 4,162,114	UniSTS	GRCh37
Build 36	16	4,101,976 - 4,102,115	RGD	NCBI36
Celera	16	4,368,667 - 4,368,806	RGD
Cytogenetic Map	16	p13.3	UniSTS
HuRef	16	4,130,095 - 4,130,234	UniSTS
TNG Radiation Hybrid Map	16	2519.0	UniSTS
GeneMap99-G3 RH Map	16	2994.0	UniSTS

G35896

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	16	4,068,105 - 4,068,203	UniSTS	GRCh37
Build 36	16	4,008,106 - 4,008,204	RGD	NCBI36
Celera	16	4,274,779 - 4,274,877	RGD
Cytogenetic Map	16	p13.3	UniSTS
HuRef	16	4,036,189 - 4,036,287	UniSTS

RH68479

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	16	4,118,132 - 4,118,264	UniSTS	GRCh37
Build 36	16	4,058,133 - 4,058,265	RGD	NCBI36
Celera	16	4,324,820 - 4,324,952	RGD
Cytogenetic Map	16	p13.3	UniSTS
HuRef	16	4,086,256 - 4,086,388	UniSTS
GeneMap99-GB4 RH Map	16	62.5	UniSTS

1952

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	16	4,013,242 - 4,013,329	UniSTS	GRCh37
Build 36	16	3,953,243 - 3,953,330	RGD	NCBI36
Celera	16	4,219,890 - 4,219,977	RGD
Cytogenetic Map	16	p13.3	UniSTS
HuRef	16	3,981,598 - 3,981,685	UniSTS
GeneMap99-GB4 RH Map	16	67.32	UniSTS

STS-Z40718

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	16	4,012,758 - 4,012,823	UniSTS	GRCh37
Build 36	16	3,952,759 - 3,952,824	RGD	NCBI36
Celera	16	4,219,428 - 4,219,493	RGD
Cytogenetic Map	16	p13.3	UniSTS
HuRef	16	3,981,136 - 3,981,201	UniSTS
GeneMap99-GB4 RH Map	16	66.28	UniSTS

G35540

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	16	4,086,309 - 4,086,427	UniSTS	GRCh37
Build 36	16	4,026,310 - 4,026,428	RGD	NCBI36
Celera	16	4,293,006 - 4,293,124	RGD
Cytogenetic Map	16	p13.3	UniSTS
HuRef	16	4,054,435 - 4,054,553	UniSTS

D16S758

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	16	4,119,215 - 4,119,461	UniSTS	GRCh37
Build 36	16	4,059,216 - 4,059,462	RGD	NCBI36
Celera	16	4,325,903 - 4,326,155	RGD
Cytogenetic Map	16	p13.3	UniSTS
HuRef	16	4,087,339 - 4,087,582	UniSTS

D16S2995

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	16	4,170,184 - 4,170,311	UniSTS	GRCh37
Build 36	16	4,110,185 - 4,110,312	RGD	NCBI36
Celera	16	4,376,881 - 4,377,008	RGD
Cytogenetic Map	16	p13.3	UniSTS
HuRef	16	4,137,805 - 4,137,932	UniSTS

D22S1584

Human Assembly	Chr	Position (strand)	Source
Cytogenetic Map	5	q31.2	UniSTS
Cytogenetic Map	2	q33.1	UniSTS
Cytogenetic Map	16	q24	UniSTS
Cytogenetic Map	6	q21	UniSTS
Cytogenetic Map	19	p13.3	UniSTS
Cytogenetic Map	11	p15.4	UniSTS
Cytogenetic Map	5	q35.3	UniSTS
Cytogenetic Map	7	q22.1	UniSTS
Cytogenetic Map	2	q35	UniSTS
Cytogenetic Map	5	q13.2	UniSTS
Cytogenetic Map	16	p13.13	UniSTS
Cytogenetic Map	22	q11.21	UniSTS
Cytogenetic Map	17	q11.2	UniSTS
Cytogenetic Map	5	q31	UniSTS
Cytogenetic Map	5	q31.3	UniSTS
Cytogenetic Map	22	q11.2	UniSTS
Cytogenetic Map	7	q21.2	UniSTS
Cytogenetic Map	16	p11.2	UniSTS
Cytogenetic Map	19	q13.12	UniSTS
Cytogenetic Map	2	q33-q34	UniSTS
Cytogenetic Map	19	q13.1-q13.2	UniSTS
Cytogenetic Map	16	q22.1	UniSTS
Cytogenetic Map	19	q13.1	UniSTS
Cytogenetic Map	2	q32-q34	UniSTS
Cytogenetic Map	3	q23	UniSTS
Cytogenetic Map	10	p15-p14	UniSTS
Cytogenetic Map	1	q25.2	UniSTS
Cytogenetic Map	19	q13.32	UniSTS
Cytogenetic Map	20	q11.23	UniSTS
Cytogenetic Map	19	q13.31	UniSTS
Cytogenetic Map	2	p14	UniSTS
Cytogenetic Map	16	p13.3	UniSTS
Cytogenetic Map	1	p34.3	UniSTS
Cytogenetic Map	1	p36.11	UniSTS
Cytogenetic Map	5	q33.1	UniSTS
Cytogenetic Map	16	p12.2	UniSTS
Cytogenetic Map	17	q12	UniSTS
Cytogenetic Map	10	q24.2	UniSTS

Expression

RNA-SEQ Expression

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

Download All Expressed Objects for this Gene

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	pharyngeal arch	renal system	reproductive system	respiratory system	sensory system	visual system
1204	2437	2788	2246	4969	1726	2349	5	624	1907	465	2268	7263	6431	52	3732	1	852	1742	1614	174	1

Sequence

Nucleotide Sequences


RefSeq Transcripts	NG_011434	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_001116	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_005255079	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_011522353	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054379509	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054379510	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AB011092	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AC005736	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AF036927	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AH010599	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AJ133123	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK022108	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AU141090	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AW518323	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC068612	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC136657	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC136658	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC151207	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC151229	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BI770493	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BQ614080	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471112	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068262	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DQ005545	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DQ008441	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	KF454950	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	KF456147	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	KF456149	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	KF456154	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000294016 ⟹ ENSP00000294016

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	16	3,962,653 - 4,116,442 (-)	Ensembl

Ensembl Acc Id:

ENST00000571467 ⟹ ENSP00000460160

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	16	3,989,084 - 4,113,925 (-)	Ensembl

Ensembl Acc Id:

ENST00000571889

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	16	3,989,089 - 4,054,190 (-)	Ensembl

Ensembl Acc Id:

ENST00000572288 ⟹ ENSP00000461825

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	16	3,992,222 - 4,114,026 (-)	Ensembl

Ensembl Acc Id:

ENST00000574721

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	16	3,981,773 - 3,984,150 (-)	Ensembl

Ensembl Acc Id:

ENST00000575550

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	16	3,983,392 - 4,015,682 (-)	Ensembl

Ensembl Acc Id:

ENST00000576936 ⟹ ENSP00000460066

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	16	3,953,387 - 3,989,000 (-)	Ensembl

RefSeq Acc Id:

NM_001116 ⟹ NP_001107

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	16	3,962,653 - 4,116,442 (-)	NCBI
GRCh37	16	4,012,650 - 4,166,186 (-)	ENTREZGENE
Build 36	16	3,952,653 - 4,106,187 (-)	NCBI Archive
HuRef	16	3,981,028 - 4,147,934 (-)	ENTREZGENE
CHM1_1	16	4,012,672 - 4,166,128 (-)	NCBI
T2T-CHM13v2.0	16	3,989,986 - 4,143,751 (-)	NCBI

Sequence:

show sequence

AGTGACAGCGGGCGGGGCAGGGGCCGGAGATGGTGGCGGCGGCAGCTCTTCCGACATGAGGCAG
CGGCCGCGGGGGACACGGCGGCGGGCGCGGCGGCGGCCGCATCTCTAGCTCGGGGAGGCGGCCC
CCGGCGTGGGCGCGGGCGGGCGGGCGTCCCGGCCGGCGTCGCGGGAGCCCGGCTCTGCGGCAGC
GTCTGCACCGCCGCCCGGCGAGGGGCCCGCGTCCGTGGTTCCACGCGCTCGGTCCCGGGACAGC
TGCGGCCGCGGCGGGAGCGGCGGCGCACTCGGGGGGAAGCAGGCCCCACTAGACGGGCCGCGCC
GACGGGCTCCGCGCACTCGCAGCCCGGGGCGCCCCCACCCCCAGCGCCCGCCGCCGCGGGCAGG
GCCGGCCCGGAGCGCGGGGGGCGGCCGGGGAGCGCGAGCCGGGGGCGCCCGCCGAAGCTCGCTG
CTCCGGGTCGGGGTCCGGGCCCGGGGCCGGCCGCGCGCCGCCTTTGACGCATCGGAGCGCGGCT
CCTGCAGGATGGAGGGCTCCGCGCCGCCAGCGGAGTTGTTTGTGCGCAGGCGGCTCGCGGGGCT
GGGAGCGCTCAAGGTCTGAACTTCCCTCCGGAGCCGCAGCTGGAGGAGGCGAGCGCGCGAGGAG
GAGAAGCCGCGCGGCGCGGAGGCCACCCTCGGGGCGAGAGGCGCGGAAGGCGAGCGAGCAAAGC
GGTCCCGGAGCCACGGCGGCCACGCGGCGGGGACCCCCGGGCGTTCTAGGTACTGGTGACCCCG
GCCGGGGCAGGCCCCGGGACTCGACAACATGGCTTCCCCACCCCACCAGCAGCTGCTGCATCAC
CACAGCACCGAGGTGAGCTGCGACTCCAGCGGGGACAGCAACAGCGTGCGCGTCAAGATCAACC
CCAAGCAGCTGTCCTCCAACAGCCACCCCAAGCACTGCAAATACAGCATCTCCTCTAGCTGCAG
CAGCTCTGGGGACTCCGGGGGCGTCCCCCGGCGAGTGGGCGGCGGAGGCCGGCTGCGCAGGCAG
AAGAAGCTGCCCCAGCTGTTCGAGAGGGCCTCCAGCCGCTGGTGGGACCCCAAGTTCGACTCGG
TGAACCTGGAGGAGGCCTGCCTGGAGCGCTGCTTCCCGCAGACCCAGCGCCGGTTCCGGTATGC
GCTCTTCTACATCGGCTTCGCCTGCCTTCTGTGGAGCATCTATTTTGCGGTCCACATGAGATCC
AGACTGATCGTCATGGTCGCCCCCGCGCTGTGCTTCCTCCTGGTGTGTGTGGGCTTCTTTCTGT
TTACCTTCACCAAGCTGTACGCCCGGCATTACGCGTGGACCTCGCTGGCTCTCACCCTGCTGGT
GTTCGCCCTGACCCTGGCTGCGCAGTTCCAGGTCTTGACGCCTGTCTCAGGACGCGGCGACAGC
TCCAACCTTACGGCCACAGCCCGGCCCACAGATACTTGCTTATCTCAAGTGGGGAGCTTCTCCA
TGTGCATCGAAGTGCTCTTTTTGCTCTATACCGTCATGCACTTACCTTTGTACCTGAGTTTGTG
TCTGGGGGTGGCCTACTCTGTCCTTTTCGAGACCTTTGGCTACCATTTCCGGGATGAAGCCTGC
TTCCCCTCGCCCGGAGCCGGGGCCCTGCACTGGGAGCTGCTGAGCAGGGGGCTGCTCCACGGCT
GCATCCACGCCATCGGGGTCCACCTGTTCGTCATGTCCCAGGTGAGGTCCAGGAGCACCTTCCT
CAAGGTGGGGCAATCCATTATGCACGGGAAGGACCTGGAAGTGGAAAAAGCCCTCAAAGAGAGG
ATGATTCATTCCGTGATGCCAAGAATCATAGCCGATGACTTAATGAAGCAGGGAGATGAGGAGA
GTGAGAATTCTGTCAAGAGGCATGCCACCTCGAGCCCCAAGAACAGGAAGAAAAAGTCTTCCAT
CCAAAAAGCTCCTATAGCCTTCCGCCCTTTTAAGATGCAGCAGATCGAAGAAGTCAGTATTTTA
TTTGCAGATATCGTGGGCTTCACCAAGATGAGTGCCAACAAGTCTGCCCACGCCCTGGTGGGTC
TCCTGAACGATCTGTTCGGTCGCTTCGACCGCCTGTGTGAGGAGACCAAGTGTGAGAAAATCAG
CACCCTGGGAGACTGTTACTACTGCGTGGCGGGCTGTCCCGAGCCCCGGGCCGACCATGCCTAC
TGCTGCATCGAGATGGGCCTGGGCATGATCAAGGCCATCGAGCAGTTCTGCCAGGAGAAGAAGG
AGATGGTGAACATGAGAGTCGGGGTGCACACGGGCACCGTCCTTTGCGGCATCCTGGGCATGAG
GAGGTTTAAATTTGACGTGTGGTCCAACGATGTGAACCTGGCCAATCTCATGGAGCAGCTGGGA
GTGGCCGGCAAAGTTCACATTTCTGAGGCCACCGCAAAATACTTAGATGACCGGTACGAAATGG
AAGATGGGAAAGTTATTGAACGGCTGGGCCAGAGCGTGGTTGCTGACCAGTTGAAAGGTTTGAA
GACATACCTGATATCGGGTCAGAGAGCCAAGGAGTCTCGCTGCAGCTGTGCAGAGGCCTTGCTT
TCTGGCTTTGAGGTCATTGACGGCTCACAGGTGTCCTCAGGCCCTAGGGGACAGGGGACAGCGT
CATCAGGGAATGTCAGTGACTTGGCGCAGACTGTCAAAACCTTTGATAACCTTAAGACCTGCCC
TTCGTGCGGAATCACATTTGCTCCCAAATCTGAAGCCGGCGCCGAGGGAGGAGCACCTCAAAAC
GGCTGCCAAGACGAGCATAAAAACAGCACCAAGGCTTCTGGAGGACCTAATCCCAAAACTCAGA
ACGGGCTCCTCAGCCCTCCCCAAGAGGAGAAGCTCACCAACAGTCAGACTTCTCTGTGTGAGAT
CTTGCAGGAGAAGGGAAGGTGGGCAGGGGTGAGCCTGGACCAGTCGGCTCTCCTTCCGCTGAGG
TTCAAGAACATCCGGGAGAAAACGGACGCCCACTTTGTGGACGTTATCAAAGAAGACAGCCTGA
TGAAAGATTACTTTTTTAAGCCGCCCATTAATCAGTTCAGCCTGAACTTCCTGGATCAGGAGCT
GGAGCGATCCTACAGGACCAGCTATCAGGAAGAGGTCATAAAGAACTCCCCCGTGAAGACGTTT
GCTAGTCCCACCTTCAGCTCCCTCCTGGATGTGTTTCTGTCGACCACAGTGTTTCTGACGCTGT
CCACCACCTGCTTCCTGAAGTACGAGGCGGCCACCGTGCCTCCCCCGCCCGCCGCCCTGGCGGT
CTTCAGTGCAGCCCTGCTGCTGGAGGTGCTGTCCCTCGCGGTGTCCATCAGGATGGTGTTCTTC
CTGGAGGACGTCATGGCCTGCACCAAGCGCCTGCTGGAGTGGATCGCCGGCTGGCTACCACGTC
ACTGCATCGGGGCCATCCTGGTGTCGCTTCCCGCACTGGCCGTCTACTCCCATGTCACCTCCGA
ATATGAGACCAACATACACTTCCCAGTGTTCACAGGCTCGGCCGCGCTGATTGCCGTCGTGCAC
TACTGTAACTTCTGCCAGCTCAGCTCCTGGATGAGGTCCTCCCTCGCCACCGTCGTGGGGGCCG
GGCCGCTGCTCCTGCTCTACGTCTCCCTGTGCCCAGACAGTTCTGTATTAACTTCGCCCCTTGA
CGCAGTACAGAATTTCAGTTCCGAGAGGAACCCGTGCAATAGTTCGGTGCCGCGTGACCTCCGG
CGGCCCGCCAGCCTCATCGGCCAGGAGGTGGTTCTCGTCTTCTTTCTCCTGCTCTTGTTGGTCT
GGTTCCTGAATCGCGAATTTGAAGTCAGCTACCGCCTCCACTACCACGGAGACGTGGAAGCGGA
TCTTCACCGCACCAAGATCCAGAGCATGCGGGACCAGGCAGACTGGCTGCTGAGGAACATCATC
CCCTACCACGTGGCTGAGCAGCTGAAGGTGTCCCAGACCTACTCCAAGAACCATGACAGCGGAG
GGGTGATCTTCGCCAGCATCGTCAACTTCAGCGAGTTCTACGAGGAGAACTACGAGGGCGGCAA
GGAGTGCTACCGGGTCCTCAACGAGCTCATCGGGGACTTTGACGAGCTCCTAAGCAAGCCGGAC
TACAGCAGCATCGAGAAGATCAAGACCATCGGAGCCACGTACATGGCGGCGTCAGGGCTGAACA
CCGCGCAGGCCCAGGACGGCAGCCACCCGCAGGAGCACCTGCAGATCCTGTTCGAGTTCGCCAA
GGAGATGATGCGCGTGGTGGACGACTTCAACAACAACATGCTGTGGTTCAACTTCAAGCTCCGC
GTCGGCTTCAACCATGGGCCCCTCACGGCCGGGGTCATCGGCACCACCAAGCTGCTGTACGACA
TCTGGGGAGACACCGTCAACATCGCCAGCAGGATGGACACCACCGGCGTGGAGTGCCGCATCCA
GGTGAGCGAAGAGAGCTACCGCGTCTTGAGCAAGATGGGCTATGACTTCGACTACAGAGGGACC
GTGAATGTCAAGGGGAAAGGCCAGATGAAGACCTACCTGTACCCAAAGTGCACGGATCACAGGG
TCATCCCACAGCACCAGCTGTCCATCTCCCCAGACATCCGCGTCCAGGTGGATGGCAGCATCGG
ACGGTCTCCCACAGACGAGATTGCCAACCTGGTGCCTTCTGTCCAGTATGTGGACAAGACATCT
CTGGGTTCTGACAGCAGCACGCAGGCCAAGGATGCCCACCTGTCCCCCAAGAGACCGTGGAAGG
AGCCCGTCAAAGCCGAAGAAAGGGGTCGATTTGGCAAAGCCATAGAGAAAGACGACTGTGACGA
AACAGGAATAGAAGAAGCCAACGAACTCACCAAGCTCAACGTTTCAAAGAGTGTGTGAGGCGGC
GCCCACCCGCTGCCCGAGGTGCTCTGTTTGTCGAAACACAGTAATATTTGTATTTGGCTGTTGT
GCTTTCCAAGCGCCACAGTTGCCCTCCCCGGACGTGGTGTTATGTGGTCATTTCAGCCCTAACT
TCTGTGTGGATCACAGTTATTCAGGGTTCATTTTCATCCATTCTTCCCTTTCGCTCCCTTCCCT
GGAAACCCCGCTGCCTCTGGGTCATCCGTTCAGCACGTGGTGGAGAACAAGTGCCTTCAGGGCT
GGCCTCGGCCTCGAGTCTCGGGACAGAGGCCGCCAGTGGAGATCATGGCTTTGGGTATTATTTG
ACTTTTAGAACAAAAGCTGTGGTTAAGATCTCATTTTTATTGCTTTTTCCCACGTCCCACGAGA
CACTATTTTCGGTTCTCTGGCTAATACCCTGTTTTTGAGTTTATTTTGTTTCTGTCTATGTCAC
AGTGTTCCTCTACGACCCGACCTCTCTATGTAAGCACACATGCGCACACACACTTGCATTCATG
AATCTGATATAAAGTGCCAGTAATCCGCCAAGAGGGGGTGCGAAGGGGGCATGTCACGACAGCT
CCGCCACCCCCCATTGCCCACCCGCACTTTCCCGAGCACCGCGCCCCGTGGGCTGTGGGTGAGC
CGCGCTCCCTGCACTGAGCGGGTTTAGGGGCTCGCCCACATGCATGCAGGCCAAGACAGCAAAT
GCCAGCCGGGCACGACGCCCGTGTGCCCAGGCCTCGGGGGTCTCAGAGCCGCCTCTCACCCCCG
ACCCTCCACCCAGGGGTCTCCCCATCGGGAGTGGAGGTGTTGGTCCTGGAAGCTGACTCATCGG
AGAGGGAAATACCAAATAAACATCCGAGGTTGCATTTATTTATTTATTTATTTACCCGGAAGCA
TGTGCGCTCCCGGGAGGGGTGCTGGGTCCTCAGGGTGGGGGGTCATAGCCACAGGGGAGGGCAG
TTCCCAGGAAGGTAACCAGATGTCTCTTTTGTGTTTTGGCCACCTGGGGCCGCCCCCAACCTCC
CCACCCCAAGAGGGGTCTGAGTGGGACCTCAAAGCATGGCCAGTGCAATTCTGAGGCTAGGGGA
ATAGGAGAAGCCCACCAGCTGCCCCTGCCACCCACGGGGGCTCCTCCCTGCCGGGGTCCAGCTC
AGAACCACGGGGGTCTGTGCCGGCAGCACCGGTGCCATCTTGGCTTCCACAAATTCCAGAAGTT
TCTTGGCTGCCTCCCGCTCTCAGATGGCACAGGGCCTATCAGTGGCAGGATTTAATCTGGGGAG
CAAATTCCAGCTCTGAAATGGAGTTCTCACACCGTATCTAGGGACAGAGGCATCTGGATGCAAA
CGCGGGGTTTGTTAGGGGCGGAATCCCGAGGGTGGTGTGGGGGAGCTCCGTCCGGGCAGTTGGC
TGCTGGTCCTGTCTGATTATGTTTTGCCATATTGAGTCTGAAGTTTGTGTGGAAGTGAGCTCGC
CCGAGTTGTCCGGTCGGAGTTGTAGCCAGTCTTTCAGGGGACCCCGGGACGCTGATGAGGCCCA
GGGTGCACTCCTTGTCAGTCTTGCCCGTTGTCCCTGTGCATTTTGCTTTCCGCTGTCAAATCTC
ACTGTCTCGTTTTCACACCGCATCAGTCCCCATCATCACTACTCCTCCCCAGAGACATACAGAT
TGCCCTCCCCGGCATGAAGAAGTCACAATTCTGACCCGCCACCTCTCCAGGGGCGGTGCCTGGG
ATGGCCACCCATCAGGACAGCCAGAGCCAGGGTCCCGGCGTCCTGAGAGTCCAGGGCACCTCCC
CCCATTAGCTGTAAGGTTTCCTGTCAGGTGTGACTGTCAGTTTGCTGGTCTTCCAATACCGAAG
AAAGGGTGGTTGTGACAATACCTCTTGCTTCTAAAGAATGTATTATAAAACACCGCAGATTTTT
TTTTTTCCTTAAAAAACACTACCTGATGCTTTCCTTGTTCGTGGGGATTGTGGTCACATGAAGC
TCTTTCTGCATCAGTATTAAGGTGTATATTTGAATGTCCTCCCCTCCCCTTTCCCCTCCAGGCT
GTGTAGCTTTGAGGGGCTGGGCGTTTGCTCACGACCTTGCTGTCTCGCTCAGAACATGCTCCGC
AAAGTTCTCCGCACACACTTCTTCCCCATCAAGCCCATTTCCTTCCCCAACCACAAAGGTGTTT
GTGATTCCTCACCCCGGGAAACCAAGGAGCTGCAAAGTGGAGTCTGGTTCAGCCCCGTGCAGAC
TCACCCAGAGCTTAACGTTGTCTTTCAAACACCCTGAGCCTTCCTAAACAGCCAGTGCAGACGT
TCTCTCTGGGCCACGAAGCCCCTCGGGTCCTCCCCGTCCCCTGCTCCGATGCATACCTCAGTGC
AGAACCACAGAATCTCTGCAGCGGAAACGCCGTGCATCTCTTGTCTGTTGGCAGCGAGCACATC
GTGCTGGAGACACGAGTTTCTAAGCAGCTGGCACGAGGGCTGCTGACGGCATGGGTCGTGCTTC
AGGGTGGCAATACCTCTTAGGAACTTAGGGCAGGAAGCAATACTTCAGCATTGAATGTGTGTAA
ATAGTTGCTTTGAGTTGCAATTGCTATTTTCTTCTCAGTCCCAGCTCAGATCGAATTATATATC
CATATATATATATATATATATATATATATATATATATATATATATATGGTAAACAAGCACACAC
AATTTTATCCAATGCAAACAAATGTAGAGCATCAGTTACAAAACCCTCGAATAGCTTGAGAGCC
CCACAGGCTCTGCCACACCCGTGACTTCATCCACACTGACGTCACCCGCGGGGGCTCCCCCTGC
ACATTTGCACACGATCCGGAGAGCCGAAGGCCGCGTGCTTCCTGTCACATGGGCTGTAATCATT
TGTAGTTTCCAAAGACACGTCTGCATTTGAATTTCTAGATTTTCGAGGTAAGGAGTTTTTTTTA
ATTGGTTGTTTGGAAAATCACATCATGCCTAGAATCTGAAATTGAATTAGCAAGAACCGACTGT
TTGCATTTTCCATATATCCTTTTATCTGCTCTTTTTAAATTGTTAATTCTAATAATTTCAAAAT
GCATTCACTGAAGAAATGGACATTAAAATATTCTAAAATTTAAA

hide sequence

RefSeq Acc Id:

XM_005255079 ⟹ XP_005255136

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	16	3,962,653 - 4,116,442 (-)	NCBI
GRCh37	16	4,012,650 - 4,166,186 (-)	NCBI

Sequence:

show sequence

CCGCCGAAGCTCGCTGCTCCGGGTCGGGGTCCGGGCCCGGGGCCGGCCGCGCGCCGCCTTTGAC
GCATCGGAGCGCGGCTCCTGCAGGATGGAGGGCTCCGCGCCGCCAGCGGAGTTGTTTGTGCGCA
GGCGGCTCGCGGGGCTGGGAGCGCTCAAGGTCTGAACTTCCCTCCGGAGCCGCAGCTGGAGGAG
GCGAGCGCGCGAGGAGGAGAAGCCGCGCGGCGCGGAGGCCACCCTCGGGGCGAGAGGCGCGGAA
GGCGAGCGAGCAAAGCGGTCCCGGAGCCACGGCGGCCACGCGGCGGGGACCCCCGGGCGTTCTA
GGTACTGGTGACCCCGGCCGGGGCAGGCCCCGGGACTCGACAACATGGCTTCCCCACCCCACCA
GCAGCTGCTGCATCACCACAGCACCGAGGTGAGCTGCGACTCCAGCGGGGACAGCAACAGCGTG
CGCGTCAAGATCAACCCCAAGCAGCTGTCCTCCAACAGCCACCCCAAGCACTGCAAATACAGCA
TCTCCTCTAGCTGCAGCAGCTCTGGGGACTCCGGGGGCGTCCCCCGGCGAGTGGGCGGCGGAGG
CCGGCTGCGCAGGCAGAAGAAGCTGCCCCAGCTGTTCGAGAGGGCCTCCAGCCGCTGGTGGGAC
CCCAAGTTCGACTCGGTGAACCTGGAGGAGGCCTGCCTGGAGCGCTGCTTCCCGCAGACCCAGC
GCCGGTTCCGGTATGCGCTCTTCTACATCGGCTTCGCCTGCCTTCTGTGGAGCATCTATTTTGC
GGTCCACATGAGATCCAGACTGATCGTCATGGTCGCCCCCGCGCTGTGCTTCCTCCTGGTGTGT
GTGGGCTTCTTTCTGTTTACCTTCACCAAGCTGTACGCCCGGCATTACGCGTGGACCTCGCTGG
CTCTCACCCTGCTGGTGTTCGCCCTGACCCTGGCTGCGCAGTTCCAGGTCTTGACGCCTGTCTC
AGGACGCGGCGACAGCTCCAACCTTACGGCCACAGCCCGGCCCACAGATACTTGCTTATCTCAA
GTGGGGAGCTTCTCCATGTGCATCGAAGTGCTCTTTTTGCTCTATACCGTCATGCACTTACCTT
TGTACCTGAGTTTGTGTCTGGGGGTGGCCTACTCTGTCCTTTTCGAGACCTTTGGCTACCATTT
CCGGGATGAAGCCTGCTTCCCCTCGCCCGGAGCCGGGGCCCTGCACTGGGAGCTGCTGAGCAGG
GGGCTGCTCCACGGCTGCATCCACGCCATCGGGGTCCACCTGTTCGTCATGTCCCAGGTGAGGT
CCAGGAGCACCTTCCTCAAGGTGGGGCAATCCATTATGCACGGGAAGGACCTGGAAGTGGAAAA
AGCCCTCAAAGAGAGGATGATTCATTCCGTGATGCCAAGAATCATAGCCGATGACTTAATGAAG
CAGGGAGATGAGGAGAGTGAGAATTCTGTCAAGAGGCATGCCACCTCGAGCCCCAAGAACAGGA
AGAAAAAGTCTTCCATCCAAAAAGCTCCTATAGCCTTCCGCCCTTTTAAGATGCAGCAGATCGA
AGAAGTCAGTATTTTATTTGCAGATATCGTGGGCTTCACCAAGATGAGTGCCAACAAGTCTGCC
CACGCCCTGGTGGGTCTCCTGAACGATCTGTTCGGTCGCTTCGACCGCCTGTGTGAGGAGACCA
AGTGTGAGAAAATCAGCACCCTGGGAGACTGTTACTACTGCGTGGCGGGCTGTCCCGAGCCCCG
GGCCGACCATGCCTACTGCTGCATCGAGATGGGCCTGGGCATGATCAAGGCCATCGAGCAGTTC
TGCCAGGAGAAGAAGGAGATGGTGAACATGAGAGTCGGGGTGCACACGGGCACCGTCCTTTGCG
GCATCCTGGGCATGAGGAGGTTTAAATTTGACGTGTGGTCCAACGATGTGAACCTGGCCAATCT
CATGGAGCAGCTGGGAGTGGCCGGCAAAGTTCACATTTCTGAGGCCACCGCAAAATACTTAGAT
GACCGGTACGAAATGGAAGATGGGAAAGTTATTGAACGGCTGGGCCAGAGCGTGGTTGCTGACC
AGTTGAAAGGTTTGAAGACATACCTGATATCGGGTCAGAGAGCCAAGGAGTCTCGCTGCAGCTG
TGCAGAGGCCTTGCTTTCTGGCTTTGAGGTCATTGACGGCTCACAGGTGTCCTCAGGCCCTAGG
GGACAGGGGACAGCGTCATCAGGGAATGTCAGTGACTTGGCGCAGACTGTCAAAACCTTTGATA
ACCTTAAGACCTGCCCTTCGTGCGGAATCACATTTGCTCCCAAATCTGAAGCCGGCGCCGAGGG
AGGAGCACCTCAAAACGGCTGCCAAGACGAGCATAAAAACAGCACCAAGGTAACAAGCTCATGG
CTGTTGTTCCTGTCAGTTCCTCTCCTGGCGCATCCACCCAAGGCTTCTGGAGGACCTAATCCCA
AAACTCAGAACGGGCTCCTCAGCCCTCCCCAAGAGGAGAAGCTCACCAACAGTCAGACTTCTCT
GTGTGAGATCTTGCAGGAGAAGGGAAGGTGGGCAGGGGTGAGCCTGGACCAGTCGGCTCTCCTT
CCGCTGAGGTTCAAGAACATCCGGGAGAAAACGGACGCCCACTTTGTGGACGTTATCAAAGAAG
ACAGCCTGATGAAAGATTACTTTTTTAAGCCGCCCATTAATCAGTTCAGCCTGAACTTCCTGGA
TCAGGAGCTGGAGCGATCCTACAGGACCAGCTATCAGGAAGAGGTCATAAAGAACTCCCCCGTG
AAGACGTTTGCTAGTCCCACCTTCAGCTCCCTCCTGGATGTGTTTCTGTCGACCACAGTGTTTC
TGACGCTGTCCACCACCTGCTTCCTGAAGTACGAGGCGGCCACCGTGCCTCCCCCGCCCGCCGC
CCTGGCGGTCTTCAGTGCAGCCCTGCTGCTGGAGGTGCTGTCCCTCGCGGTGTCCATCAGGATG
GTGTTCTTCCTGGAGGACGTCATGGCCTGCACCAAGCGCCTGCTGGAGTGGATCGCCGGCTGGC
TACCACGTCACTGCATCGGGGCCATCCTGGTGTCGCTTCCCGCACTGGCCGTCTACTCCCATGT
CACCTCCGAATATGAGACCAACATACACTTCCCAGTGTTCACAGGCTCGGCCGCGCTGATTGCC
GTCGTGCACTACTGTAACTTCTGCCAGCTCAGCTCCTGGATGAGGTCCTCCCTCGCCACCGTCG
TGGGGGCCGGGCCGCTGCTCCTGCTCTACGTCTCCCTGTGCCCAGACAGTTCTGTATTAACTTC
GCCCCTTGACGCAGTACAGAATTTCAGTTCCGAGAGGAACCCGTGCAATAGTTCGGTGCCGCGT
GACCTCCGGCGGCCCGCCAGCCTCATCGGCCAGGAGGTGGTTCTCGTCTTCTTTCTCCTGCTCT
TGTTGGTCTGGTTCCTGAATCGCGAATTTGAAGTCAGCTACCGCCTCCACTACCACGGAGACGT
GGAAGCGGATCTTCACCGCACCAAGATCCAGAGCATGCGGGACCAGGCAGACTGGCTGCTGAGG
AACATCATCCCCTACCACGTGGCTGAGCAGCTGAAGGTGTCCCAGACCTACTCCAAGAACCATG
ACAGCGGAGGGGTGATCTTCGCCAGCATCGTCAACTTCAGCGAGTTCTACGAGGAGAACTACGA
GGGCGGCAAGGAGTGCTACCGGGTCCTCAACGAGCTCATCGGGGACTTTGACGAGCTCCTAAGC
AAGCCGGACTACAGCAGCATCGAGAAGATCAAGACCATCGGAGCCACGTACATGGCGGCGTCAG
GGCTGAACACCGCGCAGGCCCAGGACGGCAGCCACCCGCAGGAGCACCTGCAGATCCTGTTCGA
GTTCGCCAAGGAGATGATGCGCGTGGTGGACGACTTCAACAACAACATGCTGTGGTTCAACTTC
AAGCTCCGCGTCGGCTTCAACCATGGGCCCCTCACGGCCGGGGTCATCGGCACCACCAAGCTGC
TGTACGACATCTGGGGAGACACCGTCAACATCGCCAGCAGGATGGACACCACCGGCGTGGAGTG
CCGCATCCAGGTGAGCGAAGAGAGCTACCGCGTCTTGAGCAAGATGGGCTATGACTTCGACTAC
AGAGGGACCGTGAATGTCAAGGGGAAAGGCCAGATGAAGACCTACCTGTACCCAAAGTGCACGG
ATCACAGGGTCATCCCACAGCACCAGCTGTCCATCTCCCCAGACATCCGCGTCCAGGTGGATGG
CAGCATCGGACGGTCTCCCACAGACGAGATTGCCAACCTGGTGCCTTCTGTCCAGTATGTGGAC
AAGACATCTCTGGGTTCTGACAGCAGCACGCAGGCCAAGGATGCCCACCTGTCCCCCAAGAGAC
CGTGGAAGGAGCCCGTCAAAGCCGAAGAAAGGGGTCGATTTGGCAAAGCCATAGAGAAAGACGA
CTGTGACGAAACAGGAATAGAAGAAGCCAACGAACTCACCAAGCTCAACGTTTCAAAGAGTGTG
TGAGGCGGCGCCCACCCGCTGCCCGAGGTGCTCTGTTTGTCGAAACACAGTAATATTTGTATTT
GGCTGTTGTGCTTTCCAAGCGCCACAGTTGCCCTCCCCGGACGTGGTGTTATGTGGTCATTTCA
GCCCTAACTTCTGTGTGGATCACAGTTATTCAGGGTTCATTTTCATCCATTCTTCCCTTTCGCT
CCCTTCCCTGGAAACCCCGCTGCCTCTGGGTCATCCGTTCAGCACGTGGTGGAGAACAAGTGCC
TTCAGGGCTGGCCTCGGCCTCGAGTCTCGGGACAGAGGCCGCCAGTGGAGATCATGGCTTTGGG
TATTATTTGACTTTTAGAACAAAAGCTGTGGTTAAGATCTCATTTTTATTGCTTTTTCCCACGT
CCCACGAGACACTATTTTCGGTTCTCTGGCTAATACCCTGTTTTTGAGTTTATTTTGTTTCTGT
CTATGTCACAGTGTTCCTCTACGACCCGACCTCTCTATGTAAGCACACATGCGCACACACACTT
GCATTCATGAATCTGATATAAAGTGCCAGTAATCCGCCAAGAGGGGGTGCGAAGGGGGCATGTC
ACGACAGCTCCGCCACCCCCCATTGCCCACCCGCACTTTCCCGAGCACCGCGCCCCGTGGGCTG
TGGGTGAGCCGCGCTCCCTGCACTGAGCGGGTTTAGGGGCTCGCCCACATGCATGCAGGCCAAG
ACAGCAAATGCCAGCCGGGCACGACGCCCGTGTGCCCAGGCCTCGGGGGTCTCAGAGCCGCCTC
TCACCCCCGACCCTCCACCCAGGGGTCTCCCCATCGGGAGTGGAGGTGTTGGTCCTGGAAGCTG
ACTCATCGGAGAGGGAAATACCAAATAAACATCCGAGGTTGCATTTATTTATTTATTTATTTAC
CCGGAAGCATGTGCGCTCCCGGGAGGGGTGCTGGGTCCTCAGGGTGGGGGGTCATAGCCACAGG
GGAGGGCAGTTCCCAGGAAGGTAACCAGATGTCTCTTTTGTGTTTTGGCCACCTGGGGCCGCCC
CCAACCTCCCCACCCCAAGAGGGGTCTGAGTGGGACCTCAAAGCATGGCCAGTGCAATTCTGAG
GCTAGGGGAATAGGAGAAGCCCACCAGCTGCCCCTGCCACCCACGGGGGCTCCTCCCTGCCGGG
GTCCAGCTCAGAACCACGGGGGTCTGTGCCGGCAGCACCGGTGCCATCTTGGCTTCCACAAATT
CCAGAAGTTTCTTGGCTGCCTCCCGCTCTCAGATGGCACAGGGCCTATCAGTGGCAGGATTTAA
TCTGGGGAGCAAATTCCAGCTCTGAAATGGAGTTCTCACACCGTATCTAGGGACAGAGGCATCT
GGATGCAAACGCGGGGTTTGTTAGGGGCGGAATCCCGAGGGTGGTGTGGGGGAGCTCCGTCCGG
GCAGTTGGCTGCTGGTCCTGTCTGATTATGTTTTGCCATATTGAGTCTGAAGTTTGTGTGGAAG
TGAGCTCGCCCGAGTTGTCCGGTCGGAGTTGTAGCCAGTCTTTCAGGGGACCCCGGGACGCTGA
TGAGGCCCAGGGTGCACTCCTTGTCAGTCTTGCCCGTTGTCCCTGTGCATTTTGCTTTCCGCTG
TCAAATCTCACTGTCTCGTTTTCACACCGCATCAGTCCCCATCATCACTACTCCTCCCCAGAGA
CATACAGATTGCCCTCCCCGGCATGAAGAAGTCACAATTCTGACCCGCCACCTCTCCAGGGGCG
GTGCCTGGGATGGCCACCCATCAGGACAGCCAGAGCCAGGGTCCCGGCGTCCTGAGAGTCCAGG
GCACCTCCCCCCATTAGCTGTAAGGTTTCCTGTCAGGTGTGACTGTCAGTTTGCTGGTCTTCCA
ATACCGAAGAAAGGGTGGTTGTGACAATACCTCTTGCTTCTAAAGAATGTATTATAAAACACCG
CAGATTTTTTTTTTTCCTTAAAAAACACTACCTGATGCTTTCCTTGTTCGTGGGGATTGTGGTC
ACATGAAGCTCTTTCTGCATCAGTATTAAGGTGTATATTTGAATGTCCTCCCCTCCCCTTTCCC
CTCCAGGCTGTGTAGCTTTGAGGGGCTGGGCGTTTGCTCACGACCTTGCTGTCTCGCTCAGAAC
ATGCTCCGCAAAGTTCTCCGCACACACTTCTTCCCCATCAAGCCCATTTCCTTCCCCAACCACA
AAGGTGTTTGTGATTCCTCACCCCGGGAAACCAAGGAGCTGCAAAGTGGAGTCTGGTTCAGCCC
CGTGCAGACTCACCCAGAGCTTAACGTTGTCTTTCAAACACCCTGAGCCTTCCTAAACAGCCAG
TGCAGACGTTCTCTCTGGGCCACGAAGCCCCTCGGGTCCTCCCCGTCCCCTGCTCCGATGCATA
CCTCAGTGCAGAACCACAGAATCTCTGCAGCGGAAACGCCGTGCATCTCTTGTCTGTTGGCAGC
GAGCACATCGTGCTGGAGACACGAGTTTCTAAGCAGCTGGCACGAGGGCTGCTGACGGCATGGG
TCGTGCTTCAGGGTGGCAATACCTCTTAGGAACTTAGGGCAGGAAGCAATACTTCAGCATTGAA
TGTGTGTAAATAGTTGCTTTGAGTTGCAATTGCTATTTTCTTCTCAGTCCCAGCTCAGATCGAA
TTATATATCCATATATATATATATATATATATATATATATATATATATATATATATGGTAAACA
AGCACACACAATTTTATCCAATGCAAACAAATGTAGAGCATCAGTTACAAAACCCTCGAATAGC
TTGAGAGCCCCACAGGCTCTGCCACACCCGTGACTTCATCCACACTGACGTCACCCGCGGGGGC
TCCCCCTGCACATTTGCACACGATCCGGAGAGCCGAAGGCCGCGTGCTTCCTGTCACATGGGCT
GTAATCATTTGTAGTTTCCAAAGACACGTCTGCATTTGAATTTCTAGATTTTCGAGGTAAGGAG
TTTTTTTTAATTGGTTGTTTGGAAAATCACATCATGCCTAGAATCTGAAATTGAATTAGCAAGA
ACCGACTGTTTGCATTTTCCATATATCCTTTTATCTGCTCTTTTTAAATTGTTAATTCTAATAA
TTTCAAAATGCATTCACTGAAGAAATGGACATTAAAATATTCTAAAATTTAAA

hide sequence

RefSeq Acc Id:

XM_011522353 ⟹ XP_011520655

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	16	3,953,387 - 4,116,442 (-)	NCBI

Sequence:

show sequence

GCCCGCCGAAGCTCGCTGCTCCGGGTCGGGGTCCGGGCCCGGGGCCGGCCGCGCGCCGCCTTTG
ACGCATCGGAGCGCGGCTCCTGCAGGATGGAGGGCTCCGCGCCGCCAGCGGAGTTGTTTGTGCG
CAGGCGGCTCGCGGGGCTGGGAGCGCTCAAGGTCTGAACTTCCCTCCGGAGCCGCAGCTGGAGG
AGGCGAGCGCGCGAGGAGGAGAAGCCGCGCGGCGCGGAGGCCACCCTCGGGGCGAGAGGCGCGG
AAGGCGAGCGAGCAAAGCGGTCCCGGAGCCACGGCGGCCACGCGGCGGGGACCCCCGGGCGTTC
TAGGTACTGGTGACCCCGGCCGGGGCAGGCCCCGGGACTCGACAACATGGCTTCCCCACCCCAC
CAGCAGCTGCTGCATCACCACAGCACCGAGGTGAGCTGCGACTCCAGCGGGGACAGCAACAGCG
TGCGCGTCAAGATCAACCCCAAGCAGCTGTCCTCCAACAGCCACCCCAAGCACTGCAAATACAG
CATCTCCTCTAGCTGCAGCAGCTCTGGGGACTCCGGGGGCGTCCCCCGGCGAGTGGGCGGCGGA
GGCCGGCTGCGCAGGCAGAAGAAGCTGCCCCAGCTGTTCGAGAGGGCCTCCAGCCGCTGGTGGG
ACCCCAAGTTCGACTCGGTGAACCTGGAGGAGGCCTGCCTGGAGCGCTGCTTCCCGCAGACCCA
GCGCCGGTTCCGGTATGCGCTCTTCTACATCGGCTTCGCCTGCCTTCTGTGGAGCATCTATTTT
GCGGTCCACATGAGATCCAGACTGATCGTCATGGTCGCCCCCGCGCTGTGCTTCCTCCTGGTGT
GTGTGGGCTTCTTTCTGTTTACCTTCACCAAGCTGTACGCCCGGCATTACGCGTGGACCTCGCT
GGCTCTCACCCTGCTGGTGTTCGCCCTGACCCTGGCTGCGCAGTTCCAGGTCTTGACGCCTGTC
TCAGGACGCGGCGACAGCTCCAACCTTACGGCCACAGCCCGGCCCACAGATACTTGCTTATCTC
AAGTGGGGAGCTTCTCCATGTGCATCGAAGTGCTCTTTTTGCTCTATACCGTCATGCACTTACC
TTTGTACCTGAGTTTGTGTCTGGGGGTGGCCTACTCTGTCCTTTTCGAGACCTTTGGCTACCAT
TTCCGGGATGAAGCCTGCTTCCCCTCGCCCGGAGCCGGGGCCCTGCACTGGGAGCTGCTGAGCA
GGGGGCTGCTCCACGGCTGCATCCACGCCATCGGGGTCCACCTGTTCGTCATGTCCCAGGTGAG
GTCCAGGAGCACCTTCCTCAAGGTGGGGCAATCCATTATGCACGGGAAGGACCTGGAAGTGGAA
AAAGCCCTCAAAGAGAGGATGATTCATTCCGTGATGCCAAGAATCATAGCCGATGACTTAATGA
AGCAGGGAGATGAGGAGAGTGAGAATTCTGTCAAGAGGCATGCCACCTCGAGCCCCAAGAACAG
GAAGAAAAAGTCTTCCATCCAAAAAGCTCCTATAGCCTTCCGCCCTTTTAAGATGCAGCAGATC
GAAGAAGTCAGTATTTTATTTGCAGATATCGTGGGCTTCACCAAGATGAGTGCCAACAAGTCTG
CCCACGCCCTGGTGGGTCTCCTGAACGATCTGTTCGGTCGCTTCGACCGCCTGTGTGAGGAGAC
CAAGTGTGAGAAAATCAGCACCCTGGGAGACTGTTACTACTGCGTGGCGGGCTGTCCCGAGCCC
CGGGCCGACCATGCCTACTGCTGCATCGAGATGGGCCTGGGCATGATCAAGGCCATCGAGCAGT
TCTGCCAGGAGAAGAAGGAGATGGTGAACATGAGAGTCGGGGTGCACACGGGCACCGTCCTTTG
CGGCATCCTGGGCATGAGGAGGTTTAAATTTGACGTGTGGTCCAACGATGTGAACCTGGCCAAT
CTCATGGAGCAGCTGGGAGTGGCCGGCAAAGTTCACATTTCTGAGGCCACCGCAAAATACTTAG
ATGACCGGTACGAAATGGAAGATGGGAAAGTTATTGAACGGCTGGGCCAGAGCGTGGTTGCTGA
CCAGTTGAAAGGTTTGAAGACATACCTGATATCGGGTCAGAGAGCCAAGGAGTCTCGCTGCAGC
TGTGCAGAGGCCTTGCTTTCTGGCTTTGAGGTCATTGACGGCTCACAGGTGTCCTCAGGCCCTA
GGGGACAGGGGACAGCGTCATCAGGGAATGTCAGTGACTTGGCGCAGACTGTCAAAACCTTTGA
TAACCTTAAGACCTGCCCTTCGTGCGGAATCACATTTGCTCCCAAATCTGAAGCCGGCGCCGAG
GGAGGAGCACCTCAAAACGGCTGCCAAGACGAGCATAAAAACAGCACCAAGGTAACAAGCTCAT
GGCTGTTGTTCCTGTCAGTTCCTCTCCTGGCGCATCCACCCAAGGCTTCTGGAGGACCTAATCC
CAAAACTCAGAACGGGCTCCTCAGCCCTCCCCAAGAGGAGAAGCTCACCAACAGTCAGACTTCT
CTGTGTGAGATCTTGCAGGAGAAGGGAAGGTGGGCAGGGGTGAGCCTGGACCAGTCGGCTCTCC
TTCCGCTGAGGTTCAAGAACATCCGGGAGAAAACGGACGCCCACTTTGTGGACGTTATCAAAGA
AGACAGCCTGATGAAAGATTACTTTTTTAAGCCGCCCATTAATCAGTTCAGCCTGAACTTCCTG
GATCAGGAGCTGGAGCGATCCTACAGGACCAGCTATCAGGAAGAGGTCATAAAGAACTCCCCCG
TGAAGACGTTTGCTAGTCCCACCTTCAGCTCCCTCCTGGATGTGTTTCTGTCGACCACAGTGTT
TCTGACGCTGTCCACCACCTGCTTCCTGAAGTACGAGGCGGCCACCGTGCCTCCCCCGCCCGCC
GCCCTGGCGGTCTTCAGTGCAGCCCTGCTGCTGGAGGTGCTGTCCCTCGCGGTGTCCATCAGGA
TGGTGTTCTTCCTGGAGGACGTCATGGCCTGCACCAAGCGCCTGCTGGAGTGGATCGCCGGCTG
GCTACCACGTCACTGCATCGGGGCCATCCTGGTGTCGCTTCCCGCACTGGCCGTCTACTCCCAT
GTCACCTCCGAATATGAGACCAACATACACTTCCCAGTGTTCACAGGCTCGGCCGCGCTGATTG
CCGTCGTGCACTACTGTAACTTCTGCCAGCTCAGCTCCTGGATGAGGTCCTCCCTCGCCACCGT
CGTGGGGGCCGGGCCGCTGCTCCTGCTCTACGTCTCCCTGTGCCCAGACAGTTCTGTATTAACT
TCGCCCCTTGACGCAGTACAGAATTTCAGAAGACGAGAACCCTGTGGAGAGGGAGACTCCAAGT
TTCCCTTCAGTTCACAGGAAGAGAGTTGCCGTGCAGGAGCCTAATTGTAAATTTGAAAAAATTA
AAAACTGCTTATGCTCTGTCAATTACCAAAA

hide sequence

RefSeq Acc Id:

XM_054379509 ⟹ XP_054235484

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	16	3,989,986 - 4,143,751 (-)	NCBI

RefSeq Acc Id:

XM_054379510 ⟹ XP_054235485

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	16	3,980,710 - 4,143,751 (-)	NCBI

Protein Sequences


Protein RefSeqs	NP_001107	(Get FASTA)	NCBI Sequence Viewer
	XP_005255136	(Get FASTA)	NCBI Sequence Viewer
	XP_011520655	(Get FASTA)	NCBI Sequence Viewer
	XP_054235484	(Get FASTA)	NCBI Sequence Viewer
	XP_054235485	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAC24201	(Get FASTA)	NCBI Sequence Viewer
	AAI36658	(Get FASTA)	NCBI Sequence Viewer
	AAI36659	(Get FASTA)	NCBI Sequence Viewer
	AAI51208	(Get FASTA)	NCBI Sequence Viewer
	AAI51230	(Get FASTA)	NCBI Sequence Viewer
	AAK29464	(Get FASTA)	NCBI Sequence Viewer
	AAY21237	(Get FASTA)	NCBI Sequence Viewer
	AAY27880	(Get FASTA)	NCBI Sequence Viewer
	BAA25446	(Get FASTA)	NCBI Sequence Viewer
	CAB65084	(Get FASTA)	NCBI Sequence Viewer
	EAW85331	(Get FASTA)	NCBI Sequence Viewer
	EAW85332	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000294016
	ENSP00000294016.3
GenBank Protein	O60503	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:

NP_001107 ⟸ NM_001116

- UniProtKB:

Q9BWT4 (UniProtKB/Swiss-Prot), Q4ZIR5 (UniProtKB/Swiss-Prot), Q4ZHT9 (UniProtKB/Swiss-Prot), O60273 (UniProtKB/Swiss-Prot), D3DUD1 (UniProtKB/Swiss-Prot), A7E2X2 (UniProtKB/Swiss-Prot), A7E2V5 (UniProtKB/Swiss-Prot), Q9UGP2 (UniProtKB/Swiss-Prot), O60503 (UniProtKB/Swiss-Prot)

- Sequence:

show sequence

MASPPHQQLLHHHSTEVSCDSSGDSNSVRVKINPKQLSSNSHPKHCKYSISSSCSSSGDSGGVP
RRVGGGGRLRRQKKLPQLFERASSRWWDPKFDSVNLEEACLERCFPQTQRRFRYALFYIGFACL
LWSIYFAVHMRSRLIVMVAPALCFLLVCVGFFLFTFTKLYARHYAWTSLALTLLVFALTLAAQF
QVLTPVSGRGDSSNLTATARPTDTCLSQVGSFSMCIEVLFLLYTVMHLPLYLSLCLGVAYSVLF
ETFGYHFRDEACFPSPGAGALHWELLSRGLLHGCIHAIGVHLFVMSQVRSRSTFLKVGQSIMHG
KDLEVEKALKERMIHSVMPRIIADDLMKQGDEESENSVKRHATSSPKNRKKKSSIQKAPIAFRP
FKMQQIEEVSILFADIVGFTKMSANKSAHALVGLLNDLFGRFDRLCEETKCEKISTLGDCYYCV
AGCPEPRADHAYCCIEMGLGMIKAIEQFCQEKKEMVNMRVGVHTGTVLCGILGMRRFKFDVWSN
DVNLANLMEQLGVAGKVHISEATAKYLDDRYEMEDGKVIERLGQSVVADQLKGLKTYLISGQRA
KESRCSCAEALLSGFEVIDGSQVSSGPRGQGTASSGNVSDLAQTVKTFDNLKTCPSCGITFAPK
SEAGAEGGAPQNGCQDEHKNSTKASGGPNPKTQNGLLSPPQEEKLTNSQTSLCEILQEKGRWAG
VSLDQSALLPLRFKNIREKTDAHFVDVIKEDSLMKDYFFKPPINQFSLNFLDQELERSYRTSYQ
EEVIKNSPVKTFASPTFSSLLDVFLSTTVFLTLSTTCFLKYEAATVPPPPAALAVFSAALLLEV
LSLAVSIRMVFFLEDVMACTKRLLEWIAGWLPRHCIGAILVSLPALAVYSHVTSEYETNIHFPV
FTGSAALIAVVHYCNFCQLSSWMRSSLATVVGAGPLLLLYVSLCPDSSVLTSPLDAVQNFSSER
NPCNSSVPRDLRRPASLIGQEVVLVFFLLLLLVWFLNREFEVSYRLHYHGDVEADLHRTKIQSM
RDQADWLLRNIIPYHVAEQLKVSQTYSKNHDSGGVIFASIVNFSEFYEENYEGGKECYRVLNEL
IGDFDELLSKPDYSSIEKIKTIGATYMAASGLNTAQAQDGSHPQEHLQILFEFAKEMMRVVDDF
NNNMLWFNFKLRVGFNHGPLTAGVIGTTKLLYDIWGDTVNIASRMDTTGVECRIQVSEESYRVL
SKMGYDFDYRGTVNVKGKGQMKTYLYPKCTDHRVIPQHQLSISPDIRVQVDGSIGRSPTDEIAN
LVPSVQYVDKTSLGSDSSTQAKDAHLSPKRPWKEPVKAEERGRFGKAIEKDDCDETGIEEANEL
TKLNVSKSV

hide sequence

RefSeq Acc Id:

XP_005255136 ⟸ XM_005255079

- Peptide Label:

isoform X1

- Sequence:

show sequence

MASPPHQQLLHHHSTEVSCDSSGDSNSVRVKINPKQLSSNSHPKHCKYSISSSCSSSGDSGGVP
RRVGGGGRLRRQKKLPQLFERASSRWWDPKFDSVNLEEACLERCFPQTQRRFRYALFYIGFACL
LWSIYFAVHMRSRLIVMVAPALCFLLVCVGFFLFTFTKLYARHYAWTSLALTLLVFALTLAAQF
QVLTPVSGRGDSSNLTATARPTDTCLSQVGSFSMCIEVLFLLYTVMHLPLYLSLCLGVAYSVLF
ETFGYHFRDEACFPSPGAGALHWELLSRGLLHGCIHAIGVHLFVMSQVRSRSTFLKVGQSIMHG
KDLEVEKALKERMIHSVMPRIIADDLMKQGDEESENSVKRHATSSPKNRKKKSSIQKAPIAFRP
FKMQQIEEVSILFADIVGFTKMSANKSAHALVGLLNDLFGRFDRLCEETKCEKISTLGDCYYCV
AGCPEPRADHAYCCIEMGLGMIKAIEQFCQEKKEMVNMRVGVHTGTVLCGILGMRRFKFDVWSN
DVNLANLMEQLGVAGKVHISEATAKYLDDRYEMEDGKVIERLGQSVVADQLKGLKTYLISGQRA
KESRCSCAEALLSGFEVIDGSQVSSGPRGQGTASSGNVSDLAQTVKTFDNLKTCPSCGITFAPK
SEAGAEGGAPQNGCQDEHKNSTKVTSSWLLFLSVPLLAHPPKASGGPNPKTQNGLLSPPQEEKL
TNSQTSLCEILQEKGRWAGVSLDQSALLPLRFKNIREKTDAHFVDVIKEDSLMKDYFFKPPINQ
FSLNFLDQELERSYRTSYQEEVIKNSPVKTFASPTFSSLLDVFLSTTVFLTLSTTCFLKYEAAT
VPPPPAALAVFSAALLLEVLSLAVSIRMVFFLEDVMACTKRLLEWIAGWLPRHCIGAILVSLPA
LAVYSHVTSEYETNIHFPVFTGSAALIAVVHYCNFCQLSSWMRSSLATVVGAGPLLLLYVSLCP
DSSVLTSPLDAVQNFSSERNPCNSSVPRDLRRPASLIGQEVVLVFFLLLLLVWFLNREFEVSYR
LHYHGDVEADLHRTKIQSMRDQADWLLRNIIPYHVAEQLKVSQTYSKNHDSGGVIFASIVNFSE
FYEENYEGGKECYRVLNELIGDFDELLSKPDYSSIEKIKTIGATYMAASGLNTAQAQDGSHPQE
HLQILFEFAKEMMRVVDDFNNNMLWFNFKLRVGFNHGPLTAGVIGTTKLLYDIWGDTVNIASRM
DTTGVECRIQVSEESYRVLSKMGYDFDYRGTVNVKGKGQMKTYLYPKCTDHRVIPQHQLSISPD
IRVQVDGSIGRSPTDEIANLVPSVQYVDKTSLGSDSSTQAKDAHLSPKRPWKEPVKAEERGRFG
KAIEKDDCDETGIEEANELTKLNVSKSV

hide sequence

RefSeq Acc Id:

XP_011520655 ⟸ XM_011522353

- Peptide Label:

isoform X2

- Sequence:

show sequence

MASPPHQQLLHHHSTEVSCDSSGDSNSVRVKINPKQLSSNSHPKHCKYSISSSCSSSGDSGGVP
RRVGGGGRLRRQKKLPQLFERASSRWWDPKFDSVNLEEACLERCFPQTQRRFRYALFYIGFACL
LWSIYFAVHMRSRLIVMVAPALCFLLVCVGFFLFTFTKLYARHYAWTSLALTLLVFALTLAAQF
QVLTPVSGRGDSSNLTATARPTDTCLSQVGSFSMCIEVLFLLYTVMHLPLYLSLCLGVAYSVLF
ETFGYHFRDEACFPSPGAGALHWELLSRGLLHGCIHAIGVHLFVMSQVRSRSTFLKVGQSIMHG
KDLEVEKALKERMIHSVMPRIIADDLMKQGDEESENSVKRHATSSPKNRKKKSSIQKAPIAFRP
FKMQQIEEVSILFADIVGFTKMSANKSAHALVGLLNDLFGRFDRLCEETKCEKISTLGDCYYCV
AGCPEPRADHAYCCIEMGLGMIKAIEQFCQEKKEMVNMRVGVHTGTVLCGILGMRRFKFDVWSN
DVNLANLMEQLGVAGKVHISEATAKYLDDRYEMEDGKVIERLGQSVVADQLKGLKTYLISGQRA
KESRCSCAEALLSGFEVIDGSQVSSGPRGQGTASSGNVSDLAQTVKTFDNLKTCPSCGITFAPK
SEAGAEGGAPQNGCQDEHKNSTKVTSSWLLFLSVPLLAHPPKASGGPNPKTQNGLLSPPQEEKL
TNSQTSLCEILQEKGRWAGVSLDQSALLPLRFKNIREKTDAHFVDVIKEDSLMKDYFFKPPINQ
FSLNFLDQELERSYRTSYQEEVIKNSPVKTFASPTFSSLLDVFLSTTVFLTLSTTCFLKYEAAT
VPPPPAALAVFSAALLLEVLSLAVSIRMVFFLEDVMACTKRLLEWIAGWLPRHCIGAILVSLPA
LAVYSHVTSEYETNIHFPVFTGSAALIAVVHYCNFCQLSSWMRSSLATVVGAGPLLLLYVSLCP
DSSVLTSPLDAVQNFRRREPCGEGDSKFPFSSQEESCRAGA

hide sequence

Ensembl Acc Id:

ENSP00000294016 ⟸ ENST00000294016

Ensembl Acc Id:

ENSP00000460160 ⟸ ENST00000571467

Ensembl Acc Id:

ENSP00000461825 ⟸ ENST00000572288

Ensembl Acc Id:

ENSP00000460066 ⟸ ENST00000576936

RefSeq Acc Id:	XP_054235485 ⟸ XM_054379510
- Peptide Label:	isoform X2

RefSeq Acc Id:	XP_054235484 ⟸ XM_054379509
- Peptide Label:	isoform X1

Protein Domains

Guanylate cyclase

Protein Structures

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-O60503-F1-model_v2	AlphaFold	O60503	1-1353	view protein structure

Promoters

RGD ID:

6792770

Promoter ID:

HG_KWN:22913

Type:

CpG-Island

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

CD4+TCell_12Hour, HeLa_S3, K562, Lymphoblastoid, NB4

Transcripts:

NM_001116

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	16	4,105,856 - 4,106,782 (-)	MPROMDB

RGD ID:

7231175

Promoter ID:

EPDNEW_H21334

Type:

initiation region

Name:

ADCY9_3

Description:

adenylate cyclase 9

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H21335 EPDNEW_H21336

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	16	4,116,090 - 4,116,150	EPDNEW

RGD ID:

7231179

Promoter ID:

EPDNEW_H21335

Type:

initiation region

Name:

ADCY9_1

Description:

adenylate cyclase 9

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H21334 EPDNEW_H21336

Experiment Methods:

Single-end sequencing.; Paired-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	16	4,116,442 - 4,116,502	EPDNEW

Additional Information

External Database Links

Database	Acc Id	Source(s)
AGR Gene	HGNC:240	AgrOrtholog
COSMIC	ADCY9	COSMIC
Ensembl Genes	ENSG00000162104	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000294016	ENTREZGENE
	ENST00000294016.8	UniProtKB/Swiss-Prot
Gene3D-CATH	3.30.70.1230	UniProtKB/Swiss-Prot
GTEx	ENSG00000162104	GTEx
HGNC ID	HGNC:240	ENTREZGENE
Human Proteome Map	ADCY9	Human Proteome Map
InterPro	A/G_cyclase	UniProtKB/Swiss-Prot
	A/G_cyclase_CS	UniProtKB/Swiss-Prot
	Nucleotide_cyclase	UniProtKB/Swiss-Prot
KEGG Report	hsa:115	UniProtKB/Swiss-Prot
NCBI Gene	115	ENTREZGENE
OMIM	603302	OMIM
PANTHER	ADENYLATE CYCLASE TYPE 1	UniProtKB/Swiss-Prot
	ADENYLATE CYCLASE TYPE 9	UniProtKB/Swiss-Prot
Pfam	Guanylate_cyc	UniProtKB/Swiss-Prot
PharmGKB	ADCY9	RGD, PharmGKB
PROSITE	GUANYLATE_CYCLASE_1	UniProtKB/Swiss-Prot
	GUANYLATE_CYCLASE_2	UniProtKB/Swiss-Prot
SMART	CYCc	UniProtKB/Swiss-Prot
Superfamily-SCOP	SSF55073	UniProtKB/Swiss-Prot
UniProt	A7E2V5	ENTREZGENE
	A7E2X2	ENTREZGENE
	ADCY9_HUMAN	UniProtKB/Swiss-Prot
	D3DUD1	ENTREZGENE
	I3L300_HUMAN	UniProtKB/TrEMBL
	I3L342_HUMAN	UniProtKB/TrEMBL
	I3NI20_HUMAN	UniProtKB/TrEMBL
	L0R6C2_HUMAN	UniProtKB/TrEMBL
	O60273	ENTREZGENE
	O60503	ENTREZGENE
	Q4ZHT9	ENTREZGENE
	Q4ZIR5	ENTREZGENE
	Q9BWT4	ENTREZGENE
	Q9UGP2	ENTREZGENE
UniProt Secondary	A7E2V5	UniProtKB/Swiss-Prot
	A7E2X2	UniProtKB/Swiss-Prot
	D3DUD1	UniProtKB/Swiss-Prot
	O60273	UniProtKB/Swiss-Prot
	Q4ZHT9	UniProtKB/Swiss-Prot
	Q4ZIR5	UniProtKB/Swiss-Prot
	Q9BWT4	UniProtKB/Swiss-Prot
	Q9UGP2	UniProtKB/Swiss-Prot

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable
Gene Annotator (Functional Annotation)	Gene Annotator (Annotation Distribution)	Variant Visualizer (Genomic Variants)

InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable
InterViewer (Protein-Protein Interactions)	GViewer (Genome Viewer)	Variant Visualizer (Damaging Variants)

Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
Gene Annotator (Annotation Comparison)	OLGA (Gene List Generator)	Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable
MOET (Multi-Ontology Enrichement)	GOLF (Gene-Ortholog Location Finder)

Imported Disease Annotations - ClinVar

RGD Manual Annotations

Imported Annotations - KEGG (archival)

Imported Annotations - PID (archival)

Imported Human Phenotype Annotations - ClinVar

Send us a Message

Imported Disease Annotations - ClinVar

RGD Manual Annotations

Imported Annotations - KEGG (archival)

Imported Annotations - PID (archival)

Imported Human Phenotype Annotations - ClinVar